Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD)
Open accessAbstract
Age-related macular degeneration (AMD) is the most prevalent form of irreversible blindness worldwide in the elderly population. The pathology of dry AMD consists of degeneration of photoreceptors and the RPE, lipofuscin (A2E) accumulation, and drusen formation. Mice have been widely used for generating models that simulate human AMD features for investigating the pathogenesis, treatment and prevention of the disease. Although the mouse has no macula, focal atrophy of photorecptors and RPE, lipofuscin accumulation, and increased A2E can develop in aged mouse eyes. However, drusen are rarely seen in mice because of their simpler Bruch’s membrane and different process of lipofuscin extrusion compared with humans. Thus, analyzing basal deposits at the ultrastructural level and understanding the ultrastructural pathologic differences between various mouse AMD models are critical to comprehending the significance of research findings and response to possible therapeutic options for dry AMD. Based on the multifactorial pathogenesis of AMD, murine dry AMD models can be classified into three groups. First, genetically engineered mice that target genes related to juvenile macular dystrophies are the most common models, and they include abcr−/− (Stargardt disease), transgenic ELOVL4 (Stargardt-3 dominant inheritary disease), Efemp1R345W/R345W (Doyne honeycomb retinal dystrophy), and Timp3S156C/S156C (Sorsby fundus dystrophy) mice. Other murine models target genes relevant to AMD, including inflammatory genes such as Cfh−/−, Ccl2−/−, Ccr2−/−, Cx3cr1−/−, and Ccl2−/−/cx3cr1−/−, oxidative stress associated genes such as Sod1−/− and Sod2 knockdown, metabolic pathway genes such as neprilysin −/− (amyloid β), transgenic mcd/mcd (cathepsin D), Cp−/−/Heph−/Y (ferroxidase ceruloplasmin/hepaestin, iron metabolism), and transgenic ApoE4 on high fat and high cholesterol diet (lipid metabolism). Second, mice have also been immunologically manipulated by immunization with carboxyethylpyrrole (CEP), an oxidative fragment of DHA found in drusen, and found to present with dry AMD features. Third, natural mouse strains such as arrd2/arrd2 (Mdm gene mutation) and the senescence accelerated mice (SAM) spontaneously develop features of dry AMD like photoreceptor atrophy and thickening of Bruch’s membrane. All the aforementioned models develop retinal lesions with various features that simulate dry AMD lesions: focal photoreceptor degeneration, abnormal RPE with increased lipofuscin, basal infolding, decreased melanosomes and degeneration. However, Bruch’s membrane changes are less common. Most mice develop retinal lesions at an older age (6–24 months, depending on the models), while the Ccl2−/−/cx3cr1−/− mice develop lesions by 4–6 weeks. Although murine models present various degrees of retinal and/or RPE degeneration, classical drusen is extremely rare. Using electron microscopy, small drusenoid deposits are found between RPE and Bruch’s membrane in a few models including Efemp1 R345W/R345W, Ccl2−/−/cx3cr1−/−, neprilysin −/−, transgenic mcd/mcd, and ApoE4 transgenic mice on a high fat diet. High A2E levels are measured in the retinas of abcr−/−, transgenic ELOVL4, and Ccl2−/−/cx3cr1−/− mice. In summary, murine models provide useful tools for studying AMD pathogenesis and evaluating novel therapies for this disease. This review compares the major dry AMD murine models and discusses retinal pathology at the ultrastructural level.
AI snapshot
Written from the paper’s full text.
TL;DR
This review compares murine models of dry age-related macular degeneration (AMD) and their retinal ultrastructure, classifying them as genetically engineered, immunologically manipulated, or naturally occurring strains. It concludes that mice recapitulate many dry AMD features—RPE and photoreceptor degeneration, lipofuscin/A2E accumulation, basal deposits, and Bruch’s membrane thickening—but rarely develop classic drusen because they lack a macula and have different Bruch’s membrane and lipofuscin-handling biology.
Key findings
- The mouse retina lacks a macula and is rod-dominated (97% rods, 3% cones); Bruch’s membrane is about 0.4 μm thick and increases to 1.1 μm in 2-year-old mice. Drusen and residual bodies in Bruch’s membrane are rarely seen in aged or transgenic mice.
- Murine dry AMD models fall into three groups: genetically engineered mice (e.g., abcr−/−, ELOVL4, Efemp1R345W/R345W, Timp3S156C/S156C; inflammatory Cfh−/−, Ccl2−/−, Ccr2−/−, Cx3cr1−/−, Ccl2−/−/Cx3cr1−/−; oxidative Sod1−/− and Sod2 knockdown; metabolic neprilysin−/−, mcd/mcd, Cp−/−Heph−/Y, ApoE4/ApoB100), CEP-immunized mice, and natural strains (arrd2/arrd2, Mfrprd6, Nr2e3rd7, cpfl3, SAM).
- Reported quantitative phenotypes include: Ccl2−/−/Cx3cr1−/− mice develop drusen-like lesions by 4–6 weeks, with deposits 5–15 μm and spontaneous CNV in about 15%; Sod1−/− mice at 10 months show drusen in 86%, Bruch’s membrane about 6-fold thicker, photoreceptor loss in 17%, and CNV in about 10% older than 10 months; Sod2 knockdown shows 40% Bruch’s membrane thickening, ERG a-wave and b-wave reductions of 33% and 41%, and A2E levels more than twofold higher; cfh−/− mice have 29% Bruch’s membrane thinning; Cx3cr1−/− mice have 40% outer retinal thinning; CEP-immunized mice have about 3-fold thicker Bruch’s membrane; APO*E3-Leiden mice on high-fat/cholesterol diet show BlamD in 100% versus 33% on normal diet; Cp−/−Heph−/Y mice show 90% RPE hypertrophy at 12 months and CNV in 75% at 12–13 months and 50% at 7–9 months; SAM mice show fourfold Bruch’s membrane thickening by 8 months and CNV in 40% of SAMP8 older than 11 months; Mfrprd6 photoreceptor layer falls to 33% of original thickness by 4.5 months, 15% by 7 months, and one cell layer by 24 months; Nr2e3rd7 ERG amplitudes are 50% of normal by 16 months.
- Across models, common features include focal photoreceptor degeneration, abnormal RPE with increased lipofuscin, basal infoldings, decreased melanosomes, and degeneration; Bruch’s membrane changes are less common, and classical drusen are extremely rare. Small drusenoid deposits occur in Efemp1R345W/R345W, Ccl2−/−/Cx3cr1−/−, neprilysin−/−, mcd/mcd, and ApoE4 transgenic mice on a high-fat diet; high A2E levels are measured in abcr−/−, transgenic ELOVL4, and Ccl2−/−/Cx3cr1−/− retinas.
Methods
- Design: narrative review comparing major murine models of dry AMD and discussing retinal pathology at the ultrastructural level; models are classified into genetically engineered, immunologically manipulated, and naturally occurring strains.
- Data/sample: published literature on human AMD pathology and murine AMD models; no new primary data are presented.
- Main analysis: qualitative synthesis of histopathology, ultrastructure, molecular pathology, fundoscopy, ERG, A2E/lipofuscin, and Bruch’s membrane findings; no systematic review or meta-analysis is stated.
Limitations
- Stated in the paper: mice lack a macula; drusen are rarely seen because of simpler Bruch’s membrane and different lipofuscin extrusion compared with humans; Bruch’s membrane changes are less common; most models develop lesions at older ages (6–24 months, depending on model), except Ccl2−/−/Cx3cr1−/− mice by 4–6 weeks; classical drusen are extremely rare.
- Stated in the paper: extrapolation from mice to humans is limited because mice diverged from humans about 65 million years ago, immune system differences exist, inbred strains may differ from genetically diverse human populations, and therapies effective in mice may fail in human trials.
- Evident from the text: as a narrative review, it does not report a systematic search strategy, quality assessment, or meta-analysis; several models require further electron microscopy (e.g., APO*E3-Leiden, Mfrprd6, cpfl3), and some phenotypes are not fully characterized.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 193 cited sources checked · 0 supported · 0 flagged
- Premisenone given
Genetically engineered mice targeting juvenile macular dystrophy genes are the most common murine dry AMD models.
“First, genetically engineered mice that target genes related to juvenile macular dystrophies are the most common models”
Quote in the paperNot a substantial claim - Premisereasoning
Drusen are rarely seen in mice.
“However, drusen are rarely seen in mice because of their simpler Bruch’s membrane and different process of lipofuscin extrusion compared with humans.”
Quote in the paperSubstantial claim - Premisenone given
In early AMD, pathologic findings are found mostly in RPE and Bruch's membrane.
“In the early stages of AMD, pathologic findings are found mostly in the RPE and Bruch’s membrane.”
Quote in the paperNot a substantial claim - Premisecitation
Cholesterol and calcium accumulate in Bruch's membrane throughout adulthood.
“Cholesterol and calcium have been found to accumulate in Bruch’s membrane throughout adulthood (Sarks, 1976; Curcio et al., 2001; Pauleikhoff et al., 1990).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisenone given
RPE atrophy is often accompanied by degeneration and loss of the outer layers of the retina (photoreceptors, outer nuclear layer, and external limiting membrane).
“RPE atrophy is often accompanied by degeneration and loss of the outer layers of the retina (photoreceptors, outer nuclear layer, and external limiting membrane).”
Quote in the paperNot a substantial claim
- Premisenone given
Basal deposits between RPE and Bruch's membrane can be identified by electron microscopy early in disease.
“Early in the disease process, basal deposits, a type of waste between the RPE and Bruch’s membrane, can be identified by electron microscopy.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Age-associated changes set the stage for AMD development in individuals with a genetic predisposition and exposure to environmental risk factors.
“These age-associated changes set the stage for AMD development in individuals with a genetic predisposition and exposure to environmental risk factors.”
Quote in the paperNot a substantial claim - Premisenone given
Number and density of RPE cells in the macula decrease in early AMD.
“The number and density of RPE cells in the macula also decrease.”
Quote in the paperNot a substantial claim - Premisenone given
Small drusenoid deposits are found between RPE and Bruch's membrane in a few models including Efemp1 R345W/R345W, Ccl2−/−/cx3cr1−/−, neprilysin −/−, transgenic mcd/mcd, and ApoE4 transgenic mice on a high fat diet.
“Using electron microscopy, small drusenoid deposits are found between RPE and Bruch’s membrane in a few models including Efemp1 R345W/R345W, Ccl2−/−/cx3cr1−/−, neprilysin −/−, transgenic mcd/mcd, and ApoE4 transgenic mice on a high fat diet.”
Quote in the paperSubstantial claim - Premisenone given
Natural mouse strains arrd2/arrd2 and SAM spontaneously develop features of dry AMD like photoreceptor atrophy and thickening of Bruch's membrane.
“Third, natural mouse strains such as arrd2/arrd2 (Mdm gene mutation) and the senescence accelerated mice (SAM) spontaneously develop features of dry AMD like photoreceptor atrophy and thickening of Bruch’s membrane.”
Quote in the paperSubstantial claim - Premisenone given
Most mice develop retinal lesions at an older age (6-24 months, depending on the models).
“Most mice develop retinal lesions at an older age (6–24 months, depending on the models)”
Quote in the paperNot a substantial claim - Premisenone given
Areas of geographic atrophy may have a single layer of macrophages between the RPE basement membrane and the inner collagenous layer of Bruch's membrane with residual pigmented material.
“Areas of geographic atrophy may have a single layer of macrophages between the RPE basement membrane and the inner collagenous layer of Bruch’s membrane with residual pigmented material.”
Quote in the paperNot a substantial claim - Premisenone given
Ccl2−/−/cx3cr1−/− mice develop lesions by 4-6 weeks.
“while the Ccl2−/−/cx3cr1−/− mice develop lesions by 4–6 weeks.”
Quote in the paperNot a substantial claim - Premisenone given
Classical drusen is extremely rare in murine models.
“Although murine models present various degrees of retinal and/or RPE degeneration, classical drusen is extremely rare.”
Quote in the paperNot a substantial claim - Premisecitation
BlamD are a granular electron dense material with wide-spaced collagen between the plasma membrane and basal lamina of the RPE.
“BlamD are a granular electron dense material with wide-spaced collagen between the plasma membrane and basal lamina of the RPE (Green, 1993).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Green, 1993 source
Not checked in the free run.
- Premisenone given
High A2E levels are measured in retinas of abcr−/−, transgenic ELOVL4, and Ccl2−/−/cx3cr1−/− mice.
“High A2E levels are measured in the retinas of abcr−/−, transgenic ELOVL4, and Ccl2−/−/cx3cr1−/− mice.”
Quote in the paperNot a substantial claim - Premisecitation
Thick BlamD closely correlate with the presence of AMD.
“Thick BlamD closely correlate with the presence of AMD (Spraul and Grossniklaus, 1997).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Spraul and Grossniklaus, 1997
Not checked in the free run.
- Premisenone given
CEP-immunized mice present with dry AMD features.
“Second, mice have also been immunologically manipulated by immunization with carboxyethylpyrrole (CEP), an oxidative fragment of DHA found in drusen, and found to present with dry AMD features.”
Quote in the paperSubstantial claim - Premisenone given
Bruch's membrane changes are less common in murine models.
“However, Bruch’s membrane changes are less common.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The similar phenotype and features of both early 'dry' and late 'wet' AMD in the Ccl2−/− and Ccr2−/− mouse models highlight the role of macrophage recruitment in the pathogenesis of AMD.
“The similar phenotype and features of both early ‘dry’ and late ‘wet’ AMD in the Ccl2−/− and Ccr2−/− mouse models highlight the role of macrophage recruitment in the pathogenesis of AMD.”
Quote in the paperSubstantial claim - Premisecitation
At 18 months of age, the engorged subretinal microglial cells in Cx3cr1−/− mice appeared drusen-like on fundoscopy.
“At 18 months of age, the engorged subretinal microglial cells appeared drusen-like on fundoscopy (Combadiere et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Combadiere et al., 2007 source
Not checked in the free run.
- Interpretationcitation
The presence of an inflammatory cell component at the site of breaks in Bruch's membrane strongly suggests that the immune system is intricately involved in disease progression.
“The presence of an inflammatory cell component at the site of breaks in Bruch’s membrane strongly suggests that the immune system is intricately involved in disease progression (van der Schaft et al., 1992; Spraul and Grossniklaus, 1997; Anderson et al., 2002; Chan et al., 2008; Patel and Chan, 2008).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
After 9 months of age, subretinal deposits similar to drusen were noted in Ccr2−/− mice.
“After 9 months of age, subretinal deposits similar to drusen were noted in the Ccr2−/− mice.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ambati et al., 2003 source
Not checked in the free run.
- Premisecitation
cfh−/− mice have poor visual function at two years of age.
“a cfh−/− mouse model was made and found to have poor visual function at two years of age (Coffey et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Coffey et al., 2007 source
Not checked in the free run.
- Premisecitation
Ccr2−/− mice developed a phenotype very similar to Ccl2−/− mice.
“The Ccr2−/− mice developed a phenotype very similar to Ccl2−/− mice.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ambati et al., 2003 source
Not checked in the free run.
- Premisecitation
Both Ccl2−/− and Ccr2−/− murine models were found to have features of AMD.
“Both Ccl2−/− and Ccr2−/− murine models were found to have features of AMD (Ambati et al., 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ambati et al., 2003 source
Not checked in the free run.
- Premisecitation
In Ccl2−/− mice, deposition of IgG, C5, vitronectin, CD46, serum amyloid P, and advanced glycosylation endproducts was present in a distribution similar to human AMD eyes.
“In this model, deposition of IgG, C5, vitronectin, CD46, serum amyloid P, and advanced glycosylation endproducts were present in Ccl2−/− mice in a distribution similar to what has been previously reported in humans AMD eyes (Ambati et al., 2003; Mullins et al., 2000).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Homozygosity of the CX3CR1 M280 allele and V249I allele, associated with impaired microglial cell migration, has been shown to increase the risk of AMD.
“Homozygosity of the CX3CR1 M280 allele and V249I allele, associated with impaired microglial cell migration, has been shown to increase the risk of AMD (Combadiere et al., 2007; Tuo et al., 2004).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The number of lipofuscin granules and the A2E signal increased with age in senescent Ccl2−/− mice.
“Additionally, the number of lipofuscin granules and the A2E signal increased with age in senescent Ccl2−/− mice (Ambati et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ambati et al., 2003 source
Not checked in the free run.
- Premisecitation
At 12 months of age, ultrastructural analysis of senescent Cx3cr1−/− mice revealed subretinal cells that contained intracellular lipid deposits and outer segment remnants between the photoreceptor outer segment and RPE.
“At 12 months of age, ultrastructural analysis of senescent Cx3cr1−/− mice revealed subretinal cells that contained intracellular lipid deposits and outer segment remnants between the photoreceptor outer segment and RPE.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Combadiere et al., 2007 source
Not checked in the free run.
- Premisecitation
cfh−/− mice have a decrease in sub-RPE electron-dense material compared to age-matched wild-type mice.
“There is a decrease in the amount of sub-RPE electron-dense material when compared to age-matched wild-type mice (Coffey et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Coffey et al., 2007 source
Not checked in the free run.
- Premisecitation
In cfh−/− mice, melanosomes, lipofuscin granules, and melanosome-lipofuscin granules are dispersed throughout the RPE, compared to primarily apical localization in controls.
“Melanosomes, lipofuscin granules, and melanosome-lipofuscin granules were dispersed throughout the RPE in cfh−/− mice, compared to primarily apical localization of organelles observed in controls (Coffey et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Coffey et al., 2007 source
Not checked in the free run.
- Premisecitation
Bruch's membrane was markedly thickened with internal fragmentation and disruption of the collagen and elastin layers in 10 to 12 month old Ccl2−/− mice compared to age-matched wild-type mice.
“Bruch’s membrane was markedly thickened with internal fragmentation and disruption of the collagen and elastin layers in 10 to 12 month old Ccl2−/− mice compared to age-matched wild-type mice (Ambati et al., 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ambati et al., 2003 source
Not checked in the free run.
- Premisecitation
Serum albumin is one of the major proteins modified with CEP.
“Serum albumin is one of the major proteins modified with CEP”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The Ccl2−/−/Cx3cr1−/− mouse model has demonstrated early onset of the AMD phenotype with high penetrance.
“The Ccl2−/−/Cx3cr1−/− mouse model has demonstrated early onset of the AMD phenotype with high penetrance (Tuo et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tuo et al., 2007 source
Not checked in the free run.
- Premisecitation
CEP is pro-angiogenic via a VEGF-independent pathway.
“CEP is also pro-angiogenic via a VEGF-independent pathway (Ebrahem et al., 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ebrahem et al., 2006 source
Not checked in the free run.
- Premisecitation
ERG abnormalities (reduced a-wave and b-wave amplitudes) were present in transgenic mcd/mcd mice at 12 months of age.
“ERG abnormalities (reduced a-wave and b-wave amplitudes) were present in transgenic mcd/mcd mice at 12 months of age.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rakoczy et al., 2002 source
Not checked in the free run.
- Premisecitation
Ccl2−/−/Cx3cr1−/− mice began exhibiting drusen-like lesions on fundoscopy as early as 4-6 weeks of age.
“Ccl2−/−/Cx3cr1−/− mice began exhibiting drusen-like lesions on fundoscopy as early as 4–6 weeks of age.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tuo et al., 2007 source
Not checked in the free run.
- Premisecitation
By 12 months old, almost all mcd2/mcd2 animals developed RPE proliferation.
“These early findings progressed with age, and by 12 months old almost all the animals developed RPE proliferation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zhang et al., 2005 source
Not checked in the free run.
- Premisecitation
After 4 months, there was a 40% increase in Bruch's membrane thickness, specifically in the inner and outer collagenous zones, in Sod2 knockdown mice compared to age-matched wild-type mice.
“After 4 months, there was a 40% increase in Bruch’s membrane thickness, specifically in the inner and outer collagenous zones, in Sod2 knockdown mice compared to age-matched wild-type mice.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Justilien et al., 2007 source
Not checked in the free run.
- Premisecitation
Approximately 10% of Sod1−/− mice older than 10 months had CNV.
“Approximately 10% of mice older than 10 months had CNV (Imamura et al., 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Imamura et al., 2006 source
Not checked in the free run.
- Premisecitation
After laser injury, Cx3cr1−/− mice showed signs of significant CNV compared to wild-type mice.
“After laser injury, Cx3cr1−/− mice showed signs of significant CNV compared to wild-type mice (Combadiere et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Combadiere et al., 2007 source
Not checked in the free run.
- Premisecitation
Bruch's membrane was markedly thickened, with a thickness approximately 6-fold greater in Sod1−/− mice compared to age-matched wild-type mice.
“Bruch’s membrane was markedly thickened, with a thickness approximately 6-fold greater in Sod1−/− mice compared to age-matched wild-type mice.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Imamura et al., 2006 source
Not checked in the free run.
- Premisecitation
Three month-old mcd2/mcd2 mice showed focal areas of RPE disorganization, clumping, proliferation, and pleomorphism with attenuation, depigmentation, and atrophy.
“Three month-old mcd2/mcd2 mice showed focal areas of RPE disorganization, clumping, proliferation, and pleomorphism with attenuation, depigmentation, and atrophy.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zhang et al., 2005 source
Not checked in the free run.
- Premisecitation
In an AMD patient's outer retina and plasma, there are more CEP-modified proteins when compared to age-matched controls.
“In an AMD patient’s outer retina and plasma, there are more CEP-modified proteins when compared to age-matched controls (Crabb et al., 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Crabb et al., 2002 source
Not checked in the free run.
- Premisecitation
Imamura et al. showed that Sod1−/− mice have accelerated age-related pathologic changes in the retina reminiscent of AMD, including drusen, thickening of Bruch's membrane, and CNV.
“Imamura et al. showed that Sod1−/− mice have accelerated age-related pathologic changes in the retina reminiscent of AMD, including drusen, thickening of Bruch’s membrane, and CNV (Imamura et al., 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Imamura et al., 2006 source
Not checked in the free run.
- Premisecitation
ERG a-wave and b-wave amplitudes decreased by 33% and 41%, respectively, after 4 months in Sod2 knockdown mice.
“ERG a-wave and b-wave amplitudes were noted to decrease by 33% and 41%, respectively, after 4 months.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Justilien et al., 2007 source
Not checked in the free run.
- Interpretationcitation
These studies suggest a role of microglial cells in aging and AMD pathogenesis.
“These studies suggest a role of microglial cells in aging and AMD pathogenesis (Xu et al., 2009; McGeer et al., 2005).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Xu et al., 2009
Not checked in the free run.
- cites McGeer et al., 2005 source
Not checked in the free run.
- Premisecitation
Spontaneous CNV was present in about 15% of Ccl2−/−/Cx3cr1−/− mice.
“Spontaneous CNV was present in about 15% of Ccl2−/−/Cx3cr1−/− mice (Tuo et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tuo et al., 2007 source
Not checked in the free run.
- Interpretationreasoning
The similarities of the lesions in the Sod1−/− mouse model to human AMD lesions suggest that the Sod1−/− mouse is a suitable murine model for AMD.
“The similarities of the lesions in this mouse model to the human AMD lesions suggest that the Sod1−/− mouse is a suitable murine model for AMD.”
Quote in the paperSubstantial claim - Premisecitation
Drusen in Ccl2−/−/Cx3cr1−/− mice were smaller (5-15 μm) than classic human drusen seen in AMD patients.
“Drusen, while present, were smaller (5–15 μm) than classic human drusen seen in AMD patients.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chan et al., 2008 source
Not checked in the free run.
- Premisecitation
Aberrations in the Wnt/frizzled signaling pathway have been implicated in photoreceptor degeneration in retinitis pigmentosa patients.
“Aberrations in the Wnt/frizzled signaling pathway have been implicated in photoreceptor degeneration in retinitis pigmentosa patients”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The exacerbation of angiogenesis by CEP-immunization is reversible with administration of a monoclonal anti-CEP IgM antibody.
“a finding that is reversible with administration of a monoclonal anti-CEP IgM antibody”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ebrahem et al., 2006 source
Not checked in the free run.
- Premisecitation
Fundoscopy of CEP-immunized mice revealed patchy, reticular changes that were not present in controls.
“Fundoscopy of immunized mice revealed patchy, reticular changes that were not present in controls”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hollyfield et al., 2008 source
Not checked in the free run.
- Interpretationcitation
Abnormal Wnt/frizzled signaling in the RPE may be responsible for photoreceptor degeneration.
“abnormal Wnt/frizzled signaling in the RPE may be responsible for photoreceptor degeneration”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Compared to age-matched controls, CEP-immunized mice have significant BlamD accumulation throughout the retina.
“Compared to age-matched controls, CEP-immunized mice have significant BlamD accumulation throughout the retina.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hollyfield et al., 2008 source
Not checked in the free run.
- Premisenone given
By 3 months of age, Mfrprd6 RPE cells accumulate lipofuscin-like material and pigment.
“By 3 months of age, Mfrprd6 RPE cells accumulate lipofuscin-like material and pigment.”
Quote in the paperNot a substantial claim - Premisenone given
In the arrd2/arrd2 model, cone degeneration occurs slower than rod degeneration.
“In this model, cone degeneration occurs slower than rod degeneration.”
Quote in the paperNot a substantial claim - Premisecitation
The Nr2e3rd7 mouse has an exon 4,5 deletion in the Nr2e3 gene, causing a frameshift mutation that results in a premature stop codon.
“The Nr2e3rd7 mouse has an exon 4,5 deletion in the Nr2e3 gene, causing a frameshift mutation that results in a premature stop codon”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Akhmedov et al., 2000 source
Not checked in the free run.
- Premisecitation
Immunization of mice with CEP-modified mouse serum albumin generates a strong immunologic response against endogenous CEP adducts in the outer retina.
“immunize mice with CEP-modified mouse serum albumin, generating a strong immunologic response against endogenous CEP adducts in the outer retina”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The severity of retinal pathology in CEP-immunized mice correlated directly with the CEP-antibody titer.
“The severity of retinal pathology correlated directly with the CEP-antibody titer.”
Quote in the paperNot a substantial claim - Premisenone given
No basal deposits or Bruch's membrane changes were noted in arrd2/arrd2 mice.
“No basal deposits or Bruch’s membrane changes were noted in arrd2/arrd2 mice.”
Quote in the paperNot a substantial claim - Premisecitation
Bruch's membrane was significantly thicker (about 3 fold) in CEP-immunized mice.
“Bruch’s membrane was significantly thicker (about 3 fold) in immunized mice.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hollyfield et al., 2008 source
Not checked in the free run.
- Interpretationcitation
The arrd2/arrd2 phenotype has features similar to human progressive rod-cone degeneration and AMD.
“This phenotype has features similar to human progressive rod-cone degeneration and AMD”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationcitation
Certain mouse models of retinal degeneration help provide insight into the molecular pathology of photoreceptor loss in AMD.
“certain mouse models of retinal degeneration help provide insight into the molecular pathology of photoreceptor loss in AMD”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Analysis of a cohort of AMD patients with the human ortholog of MDM1 on chromosome 12q did not reveal an association between MDM1 and AMD.
“Analysis of a cohort of AMD patients with the human ortholog of MDM1 on chromosome 12q did not reveal an association between MDM1 and AMD”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
A splice-donor mutation with the loss of an exon in a gene encoding membrane-type frizzled protein (Mfrp) was identified in the rd6 mouse.
“A splice-donor mutation with the loss of an exon in a gene encoding membrane-type frizzled protein (Mfrp) was identified in the rd6 mouse”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kameya et al., 2002 source
Not checked in the free run.
- Premisecitation
CEP-immunization exacerbates angiogenesis in mice with laser-induced breaks in Bruch's membrane.
“CEP-immunization has also been shown to exacerbate angiogenesis in mice with laser-induced breaks in Bruch’s membrane”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ebrahem et al., 2006 source
Not checked in the free run.
- Premisecitation
Several naturally occurring mouse strains have shown features of retinal degeneration.
“Several naturally occurring mouse strains have shown features of retinal degeneration”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Chang et al., 2002 source
Not checked in the free run.
- Premisecitation
The retinal degeneration 7 mouse has a mutation in the Nr2e3 gene responsible for Goldmann Favre disease, or human enhanced S-cone syndrome (ESCS).
“The retinal degeneration 7 mouse has a mutation in the Nr2e3 gene responsible for Goldmann Favre disease, or human enhanced S-cone syndrome (ESCS)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Haider et al., 2000 source
Not checked in the free run.
- cites Chang et al., 1998
Not checked in the free run.
- Premisenone given
No aberrations in Bruch's membrane have been reported in Mfrprd6 mice.
“No aberrations in Bruch’s membrane have been reported”
Quote in the paperNot a substantial claim - Premisecitation
A murine model of naturally occurring, severe, late-onset, age-related retinal degeneration (arrd2) has a nonsense mutation in the Mdm1 gene on mouse chromosome 10 that is inherited in an autosomal recessive manner.
“A murine model of a naturally occurring, severe, late-onset, age-related, retinal degeneration (arrd2) has been identified to have a nonsense mutation in the Mdm1 gene on mouse chromosome 10 that is inherited in an autosomal recessive manner”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chang et al., 2008 source
Not checked in the free run.
- Premisecitation
The SAMP1 strain has been shown to have age-related changes in the RPE and Bruch's membrane.
“The SAMP1 strain has been shown to have age-related changes in the RPE and Bruch’s membrane”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Ogata et al., 1992
Not checked in the free run.
- cites Takada et al., 1994
Not checked in the free run.
- cites Takada et al., 1993
Not checked in the free run.
- Premisecitation
Intra-Bruch's membrane choroidal neovascularization was seen in 40% of the SAMP8 mice older than 11 months of age.
“Intra-Bruch’s membrane choroidal neovascularization was also seen in 40% of the SAMP8 mice older than 11 months of age”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Majji et al., 2000
Not checked in the free run.
- Premisecitation
Histopathology of cpfl3/cpfl3 mice demonstrates increased vacuolization and photoreceptor outer segment shortening with increased age.
“Histopathology demonstrates increased vacuolization and photoreceptor outer segment shortening with increased age”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chang et al., 2006 source
Not checked in the free run.
- Premisecitation
SAMR1 mice have age-related retinal pathology reminiscent of AMD.
“another strain of SAM mice with a longer life-span, SAMR1 mice, have age-related retinal pathology reminiscent of AMD”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Sarks, 1976 source
Not checked in the free run.
- cites Majji et al., 2000
Not checked in the free run.
- Premisecitation
The SAM family of 12 murine lines demonstrates accelerated senescence that has been developed by selective inbreeding of the AKR/J strain.
“The Senescence-Accelerated Mouse (SAM) family of 12 murine lines demonstrates accelerated senescence that has been developed by selective inbreeding of the AKR/J strain”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Takeda et al., 1994 source
Not checked in the free run.
- Premisenone given
Inflammatory genes Cfh, Ccl2, Ccr2, and Cx3cr1, oxidative stress associated genes Sod1 and Sod2, and metabolic pathway genes Neprilysin, mcd, Cp, Heph, ApoE and ApoB100 have been manipulated to create models with features of dry AMD.
“Inflammatory genes Cfh, Ccl2, Ccr2, and Cx3cr1, oxidative stress associated genes Sod1 and Sod2, and metabolic pathway genes Neprilysin, mcd, Cp, Heph, ApoE and ApoB100 have been manipulated to create models with features of dry AMD”
Quote in the paperSubstantial claim - Premisecitation
The molecular pathology of dry AMD has demonstrated a role of oxidative stress, inflammation, and metabolic dysregulation.
“The molecular pathology of dry AMD has demonstrated a role of oxidative stress, inflammation, and metabolic dysregulation”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ding et al. 2009 source
Not checked in the free run.
- Premisecitation
Rod photoreceptor cell death also expedites cone cell death.
“Rod photoreceptor cell death also expedites cone cell death”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shelley et al., 2009 source
Not checked in the free run.
- Premisecitation
At one month of age, large evenly-spaced retinal lesions are visible throughout the retina of homozygous Nr2e3rd7 mice by fundoscopy.
“At one month of age, large evenly-spaced retinal lesions are visible throughout the retina of homozygous Nr2e3rd7 mice by fundoscopy”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hawes et al., 1999
Not checked in the free run.
- Premisecitation
Most AMD cases have regional cone photoreceptor loss.
“Most AMD cases have regional cone photoreceptor loss”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sarks, 1976 source
Not checked in the free run.
- Premisereasoning
Most murine models are genetically engineered to manipulate genes that cause macular degeneration-like disease in humans or are relevant to AMD pathogenesis.
“Most murine models are genetically engineered to manipulate genes that cause macular degeneration-like disease in humans or are relevant to AMD pathogenesis.”
Quote in the paperNot a substantial claim - Premisecitation
Cone dysfunction is an important clinical predictor of AMD severity.
“cone dysfunction is an important clinical predictor of AMD severity”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hogg and Chakravarthy, 2006
Not checked in the free run.
- Premisecitation
High omega-3 diet ameliorates retinal AMD-like lesions in Ccl2−/−/Cx3cr1−/− mice.
“high omega-3 diet ameliorates retinal AMD-like lesions in Ccl2−/−/Cx3cr1−/− mice”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tuo et al., 2009 source
Not checked in the free run.
- Premisecitation
There are successful therapies for human disease that arose from mouse models.
“there are successful therapies for human disease that arose from mouse models”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationcitation
Mouse models with pathology that is similar to AMD at the ultrastructural level allow for robust preclinical studies of novel AMD therapeutics.
“Mouse models with pathology that is similar to AMD at the ultrastructural level allow for robust preclinical studies of novel AMD therapeutics.”
Quote in the paperSubstantial claim
- May combine two claims. 95
- The quote only partly states this claim. 2
- Classified as probably not a substantial claim. 37
May combine two claims.
Premisenone givenMice have simpler Bruch's membrane and a different process of lipofuscin extrusion compared with humans.
“However, drusen are rarely seen in mice because of their simpler Bruch’s membrane and different process of lipofuscin extrusion compared with humans.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenFocal atrophy of photoreceptors and RPE, lipofuscin accumulation, and increased A2E can develop in aged mouse eyes.
“Although the mouse has no macula, focal atrophy of photorecptors and RPE, lipofuscin accumulation, and increased A2E can develop in aged mouse eyes.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
PremisereasoningMurine dry AMD models can be classified into three groups: genetically engineered, immunologically manipulated, and natural mouse strains.
“Based on the multifactorial pathogenesis of AMD, murine dry AMD models can be classified into three groups.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Premisenone givenDry AMD pathology consists of degeneration of photoreceptors and the RPE, lipofuscin (A2E) accumulation, and drusen formation.
“The pathology of dry AMD consists of degeneration of photoreceptors and the RPE, lipofuscin (A2E) accumulation, and drusen formation.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationnone givenAll aforementioned murine models develop retinal lesions with various features that simulate dry AMD lesions: focal photoreceptor degeneration, abnormal RPE with increased lipofuscin, basal infolding, decreased melanosomes and degeneration.
“All the aforementioned models develop retinal lesions with various features that simulate dry AMD lesions: focal photoreceptor degeneration, abnormal RPE with increased lipofuscin, basal infolding, decreased melanosomes and degeneration.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThere is an age-related increase in thickness in Bruch's membrane and the internal limiting membrane.
“There is an age-related increase in thickness in Bruch’s membrane and the internal limiting membrane (Sarks, 1976; Ding et al., 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Premisenone givenAging induces retinal changes in RPE cell size and shape and results in accumulation of lysosomal residual bodies called lipofuscin granules.
“Aging induces retinal changes in RPE cell size and shape and results in the accumulation of lysosomal residual bodies called lipofuscin granules.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLoss of mitochondria is reported in AMD retina.
“Loss of mitochondria is also reported in AMD retina (Ding et. al, 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ding et. al, 2009 source
Not checked in the free run.
May combine two claims.
PremisecitationAt the ultrastructural level, drusen are a fine, granular, amorphous material the same electrodensity of the RPE basement membrane with vesicles, tubular structures, curly membranes and abnormal collagen.
“At the ultrastructural level, drusen are a fine, granular, amorphous material the same electrodensity of the RPE basement membrane with vesicles, tubular structures, curly membranes and abnormal collagen (Sarks, 1976).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sarks, 1976 source
Not checked in the free run.
May combine two claims.
Premisenone givenLipofuscin accumulation in RPE cells, basal deposits, drusen, and thickening of Bruch's membrane are all seen in early AMD and may continue to be present in late stages.
“Lipofuscin accumulation in RPE cells, basal deposits, drusen, and thickening of Bruch’s membrane are all seen in early AMD and may continue to be present in late stages of the disease.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDrusen are subretinal extracellular deposits composed of glycoproteins and lipids in the inner collagenous zone of Bruch's membrane.
“Drusen are subretinal extracellular deposits composed of glycoproteins and lipids in the inner collagenous zone of Bruch’s membrane (Sarks, 1976).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sarks, 1976 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenClassic pathology of advanced AMD has two forms: geographic atrophic (dry) and neovascular/exudative (wet).
“The classic pathology of advanced AMD is described as having two forms: the ‘geographic atrophic (dry)’ and ‘neovascular/exudative (wet)’ forms.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationWith age, photoreceptor cells (rods much more than cones, peripheral more than central retina) and ganglion cells decrease in number and density; RPE cells also show parallel changes and progressive cell loss.
“With age, photoreceptor cells (rods much more than cones, peripheral more than central retina) and ganglion cells, decrease in number and density; RPE cells also show parallel changes and progressive cell loss (Gao and Hollyfield, 1992; Panda-Jonas et al., 1995).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Gao and Hollyfield, 1992
Not checked in the free run.
- cites Panda-Jonas et al., 1995 source
Not checked in the free run.
May combine two claims.
PremisecitationBlinD are a more specific marker of AMD progression to late disease, and BlamD are a more reliable indicator of RPE atrophy and photoreceptor degeneration.
“BlinD are a more specific marker of AMD progression to late disease, and BlamD are a more reliable indicator of RPE atrophy and photoreceptor degeneration (van der Schaft et al., 1992; Curcio and Millican, 1999; Sarks, 1976).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
InterpretationreasoningMurine models provide useful tools for studying AMD pathogenesis and evaluating novel therapies for this disease.
“In summary, murine models provide useful tools for studying AMD pathogenesis and evaluating novel therapies for this disease.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenBlinD are lipid-rich electron dense substances with granules and vesicles external to the RPE basement membrane in the inner collagenous zone.
“BlinD are lipid-rich electron dense substances with granules and vesicles external to the RPE basement membrane in the inner collagenous zone.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAMD still has an unknown etiology, though oxidative stress to RPE cells along with immune dysregulation are leading theories of AMD pathogenesis.
“AMD still has an unknown etiology, though oxidative stress to the retinal pigment epithelium (RPE) cells along with immune dysregulation are leading theories of AMD pathogenesis (Ding et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ding et al., 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenHard, or nodular, drusen are smooth surfaced, dome-shaped structures between the RPE and Bruch's membrane that are clinically common.
“Hard, or nodular, drusen are smooth surfaced, dome-shaped structures between the RPE and Bruch’s membrane that are clinically common.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationLarge soft drusen are thought to arise from BlinD, which are 24-fold more common in eyes with AMD than age-matched controls.
“Large soft drusen are thought to arise from BlinD, which are 24-fold more common in eyes with AMD than age-matched controls (Curcio and Millican, 1999).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Curcio and Millican, 1999
Not checked in the free run.
May combine two claims.
PremisecitationAbnormalities in the distal cone axon occur with aging and increase susceptibility to AMD.
“Recently, it has been noted that abnormalities in the distal cone axon occurs with aging and increases susceptibility to AMD (Shelley et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Shelley et al., 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationClassic pathology of early AMD is multiple small or intermediate drusen (drusen size ≥63 microns but <125 microns) in the macular area.
“The classic pathology of early AMD is multiple small or intermediate drusen (drusen size of ≥ 63 microns but < 125 microns) in the macular area (Coleman et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Coleman et al., 2008 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPatients with drusen and CNV have higher circulating levels of anti-retinal antibodies compared to controls.
“Additionally, patients with drusen and CNV have higher circulating levels of anti-retinal antibodies compared to controls (Patel et al., 2005)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Patel et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationDrusen contain acute phase proteins, complement pathway components and inhibitors, apolipoproteins B and E, mucopolysaccarides, lipids, mannose, and sialic acid.
“Studies analyzing the composition of drusen have shown that drusen contain acute phase proteins (C-reactive protein, vitronectin, α-antichymotrypsin, amyloid P component, and fibrinogen), complement pathway components (C3, C5 and C5b-9 complex) and inhibitors (clusterin), apolipoproteins B and E, mucopolysaccarides, lipids, mannose, and sialic acid (Farkas et al., 1971; Mullins et al., 2000).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Premisenone givenCone degeneration and red-green cone hypertrophy are also found in advanced dry AMD.
“Cone degeneration and red-green cone hypertrophy are also found.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationLow ERp29 levels impact chaperone function and lead to accumulation of misfolded proteins which may aggregate and interfere with intracellular movement, allowing for aggregation of incompletely folded compounds such as lipofuscin and drusen to cause RPE damage.
“Low ERp29 levels impacts chaperone function and lead to the accumulation of misfolded proteins which may aggregate and interfere with intracellular movement, allowing for the aggregation of incompletely folded compounds such as lipofuscin and drusen to cause RPE damage (Li et al., 2004; Ethen et al., 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Li et al., 2004
Not checked in the free run.
- cites Ethen et al., 2006 source
Not checked in the free run.
May combine two claims.
PremisecitationLower levels of ERp29 are found in neurodegenerative diseases, in the AMD maculae, and the aging retina.
“Lower levels of the endoplasmic reticulum chaperone protein ERp29 are found in neurodegenerative diseases, in the AMD maculae, and the aging retina.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenDry AMD consists of perturbations in RPE, Bruch's membrane, photoreceptors, and choriocapillaris, leading to photoreceptor degeneration and atrophy.
“The ‘dry’ form of AMD, non-neovascular AMD, including intermediate AMD with many intermediate or large drusen (drusen size of ≥ 125 microns) and RPE alterations and advanced AMD with geographic atrophy, consists of many perturbations in the RPE, Bruch’s membrane, photoreceptors, and choriocapillaris, leading to photoreceptor degeneration and atrophy.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThere are two types of basal deposits: basal laminar deposits (BlamD) and basal linear deposits (BlinD).
“There are two types of basal deposits: basal laminar deposits (BlamD) and basal linear deposits (BlinD).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe retina adjacent to areas of geographic atrophy (junctional zones) is hyperpigmented and has hypertrophied RPE cells with occasional multinucleated giant cells.
“The retina adjacent to the areas of geographic atrophy (junctional zones) is hyperpigmented and has hypertrophied RPE cells with occasional multinucleated giant cells (Dastgheib and Green, 1994).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Dastgheib and Green, 1994
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThis profile does not significantly change with progression from early AMD to advanced stage AMD.
“and this profile does not significantly change with progression from early AMD to advanced stage AMD (Cherepanoff et al., 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cherepanoff et al., 2006 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenCNV is the hallmark of wet AMD.
“New blood vessel formation from the choroid, known as choroidal neovascularization (CNV), is the hallmark of ‘wet’ AMD.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenRPE progressively accumulates lipofuscin, leaving partially digested photoreceptors in the cytoplasm.
“The RPE progressively accumulates lipofuscin, leaving partially digested photoreceptors in the cytoplasm.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn advanced dry AMD called geographic atrophy, the RPE has well-demarcated atrophy and the neurosensory retina is severely affected.
“In the advanced stage of dry AMD called geographic atrophy, the RPE has well-demarcated atrophy and the neurosensory retina is severely affected (Coleman et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Coleman et al., 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationPhotoreceptor cell loss is most prominent in the parafovea and can progress to total photoreceptor loss and disciform degeneration.
“Photoreceptor cell loss is most prominent in the parafovea and can progress to total photoreceptor loss and disciform degeneration (Curcio et al., 1996; Sarks, 1976; Shelley et al., 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHemorrhages, exudates, and neovascular fibrous tissue may replace normal retinal architecture and result in photoreceptor atrophy.
“Hemorrhages, exudates, and neovascular fibrous tissue may replace normal retinal architecture and result in photoreceptor atrophy (Green, 1999; Kim et al., 2002).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Green, 1999
Not checked in the free run.
- cites Kim et al., 2002 source
Not checked in the free run.
May combine two claims.
PremisecitationAt 20 months of age, Ccl2−/− mice began to overexpress VEGF in the RPE, had dilated choriocapillaries, and began to have fragmentation in the outer layer of Bruch's membrane.
“At 20 months of age, Ccl2−/− mice began to overexpress VEGF in the RPE, had dilated choriocapillaries, and began to have fragmentation in the outer layer of Bruch’s membrane (Ambati et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ambati et al., 2003 source
Not checked in the free run.
May combine two claims.
PremisecitationCcr2−/− mice displayed signs of late AMD with geographic atrophy, outer retinal degeneration, and CNV.
“Ccr2−/− mice also displayed signs of late AMD with geographic atrophy, outer retinal degeneration, and CNV.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ambati et al., 2003 source
Not checked in the free run.
May combine two claims.
PremisecitationAs Ccl2−/− mice aged, they exhibited many findings of advanced AMD, including geographic atrophy, progressive outer retinal degeneration, and CNV.
“As Ccl2−/− mice aged, they exhibited many of the findings of advanced AMD, including geographic atrophy, progressive outer retinal degeneration, and CNV (Ambati et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ambati et al., 2003 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSubretinal fibrous tissue, or minimal subretinal fibrosis, and widespread RPE atrophy are also often noted in neovascular AMD.
“Subretinal fibrous tissue, or minimal subretinal fibrosis, and widespread RPE atrophy are also often noted (Coleman et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Coleman et al., 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationAt 14 months of age, Ccl2−/− mice had healthy photoreceptors, but attenuated and pyknotic photoreceptors developed by 16 months of age, while wild type mice still had normal photoreceptors.
“At 14 months of age, photoreceptors were healthy, but attenuated and pyknotic photoreceptors developed by 16 months of age, while wild type mice still had normal photoreceptors (Ambati et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ambati et al., 2003 source
Not checked in the free run.
May combine two claims.
PremisecitationAfter 9 months of age, subretinal deposits with features of drusen were observed in all Ccl2−/− mice, and the number of deposits increased with age.
“After 9 months of age, subretinal deposits with features of drusen were observed in all Ccl2−/− mice, and the number of deposits increased with age.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ambati et al., 2003 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSclerosis of the choriocapillaris is found without breaks in Bruch's membrane.
“Additionally, sclerosis of the choriocapillaris is found without breaks in Bruch’s membrane (Sarks, 1976).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sarks, 1976 source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe cfh−/− mice do not have many features of AMD; rather, thinning of Bruch's membrane and decreased drusen were found.
“Though there is a touted association between CFH and AMD, the cfh−/− mice do not have many features of AMD; rather, thinning of Bruch’s membrane and decreased drusen were found.”
Quote in the paperSubstantial claimMay combine two claims.
Premisecitationcfh−/− mice have C3 accumulation in the retina, secondary C3 deficiency, and uncontrolled C3 activation.
“The cfh−/− mice had C3 accumulation in the retina, secondary C3 deficiency, and uncontrolled C3 activation, which may increase phagocytic uptake and cause neural damage to the retina (Mullins et al., 2000; Coffey et al., 2007).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Premisecitationcfh−/− mice have significant thinning of Bruch's membrane by 29% and consistently disorganized, misaligned photoreceptor outer segments.
“Ultrastructurally, cfh−/− mice have significant thinning of Bruch’s membrane (by 29%) and consistently disorganized, misaligned photoreceptor outer segments.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Coffey et al., 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationCFH negatively regulates the complement system by inhibiting the alternative pathway either by promoting Factor I-mediated inactivation of C3b or by displacing Factor Bb from the C3bBb complex.
“CFH negatively regulates the complement system by inhibiting the alternative pathway either by promoting Factor I-mediated inactivation of C3b or by displacing Factor Bb from the C3bBb complex (Alsenz et al., 1985).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Alsenz et al., 1985 source
Not checked in the free run.
May combine two claims.
PremisecitationHomozygous deficiency of CFH in humans and mice results in complement factor alternative pathway dysregulation, membranoproliferative glomerulonephritis type II (MPGN2), and an AMD-like phenotype.
“Homozygous deficiency of CFH in humans and mice results in complement factor alternative pathway dysregulation, the inflammatory renal disease membranoproliferative glomerulonephritis type II (MPGN2), and an AMD-like phenotype (Raines et al., 1989; Leys et al., 1991).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationWhen Bruch's membrane becomes calcified and focal breaks occur, new blood vessels from the choroid form in the space under the RPE, and this CNV is the hallmark of exudative/neovascular, or 'wet' AMD.
“When Bruch’s membrane becomes calcified and focal breaks occur, new blood vessels from the choroid form in the space under the RPE, and this CNV is the hallmark of exudative/neovascular, or ‘wet’ AMD (Spraul and Grossniklaus, 1997).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Spraul and Grossniklaus, 1997
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIgG antibodies against retinal antigens are present in a complex and specific pattern in wet AMD eyes, which differs from dry AMD eyes and healthy controls.
“IgG antibodies against retinal antigens are present in a complex and specific pattern in wet AMD eyes, which differs from dry AMD eyes and healthy controls (Joachim et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Joachim et al., 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationAt 9 months of age, RPE cells in Ccl2−/− mice became swollen, vacuolated, and accumulated high electron density intracellular dense bodies.
“At 9 months of age, RPE cells became swollen, and vacuolated and high electron density intracellular dense bodies, likely melanosomes or melanolipofuscin fusion granules, accumulated.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ambati et al., 2003 source
Not checked in the free run.
May combine two claims.
PremisecitationAt 18 months of age, Cx3cr1−/− mice had significant (40%) thinning of the outer retina, mainly the outer nuclear layer, which progressed to marked degeneration of the photoreceptor layer by 4 months of age when compared to wild-type mice.
“At this age, the Cx3cr1−/− mice had significant (40%) thinning of the outer retina, mainly the outer nuclear layer, which progressed to marked degeneration of the photoreceptor layer by 4 months of age when compared to wild-type mice.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Combadiere et al., 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenNeovascular AMD often causes sudden loss of vision and presents with serous or hemorrhagic detachment of either the RPE or sensory retina.
“Neovascular AMD often causes sudden loss of vision and presents with serous or hemorrhagic detachment of either the retinal pigment epithelium or sensory retina.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAt 10 months of age, 86% of Sod1−/− mice had drusen, compared to very few drusen in age-matched wild-type mice.
“At 10 months of age, 86% of mice had drusen, compared to very few drusen in age-matched wild-type mice (Imamura et al., 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Imamura et al., 2006 source
Not checked in the free run.
May combine two claims.
PremisecitationAged apoE4 TR mice on a high-fat diet had the most severe degenerative phenotype with RPE hyperpigmentation, hypopigmentation, atrophy, disorganization of basal infoldings with electron-dense deposits, many electron-dense sub-RPE basal deposits, lipid-rich "drusenoid" deposits, disorganization with varying thickness of Bruch's membrane, and CNV of varying severity.
“Aged apoE4 TR mice on a high-fat diet had the most severe degenerative phenotype with RPE hyperpigmentation, hypopigmentation, atrophy, disorganization of basal infoldings with electron-dense deposits, many electron-dense sub-RPE basal deposits, lipid-rich “drusenoid” deposits, disorganization with varying thickness of Bruch’s membrane, and CNV of varying severity (Malek et al., 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Malek et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationIn 27 month-old Neprilysin−/− mice, the RPE developed vacuolization, loss of tight and adherence junctions, prominent basal infoldings, and subretinal accumulation of amorphous deposits and photoreceptor outer segments, implying RPE dysfunction.
“In 27 month-old Neprilysin−/− mice, the RPE developed vacuolization, loss of the tight and adherence junctions, prominent basal infoldings, and subretinal accumulation of amorphous deposits and photoreceptor outer segments, implying RPE dysfunction.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yoshida et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationThese lesions progressed to large, confluent areas of yellow deposits in the deep retina and subretinal space by 4-6 months of age and flattened atrophic areas by 6 months of age.
“These lesions progressed to large, confluent areas of yellow deposits in the deep retina and subretinal space by 4–6 months of age and flattened atrophic areas by 6 months of age (Chan et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chan et al., 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationEvidence of focal CNV was present in 75% of 12-13 month-old Cp−/−Heph−/Y mice and 50% of 7-9 month-old mice.
“Evidence of focal CNV was also present in 75% of 12–13 month-old mice and 50% of 7–9 month-old mice (Hahn et al., 2004; Hadziahmetovic et al., 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationcitationThe Ccl2−/−/Cx3cr1−/− mouse model demonstrates many AMD features: small drusenoid deposits, RPE and Bruch's membrane degenerations, photoreceptor atrophy, CNV, and simulation of the immunologic and pathologic environments found in AMD patients.
“The Ccl2−/−/Cx3cr1−/− mouse model demonstrates many AMD features: small drusenoid deposits, RPE and Bruch’s membrane degenerations, photoreceptor atrophy, CNV, and simulation of the immunologic and pathologic environments found in AMD patients (Herzlich et al., 2008; Ross et al., 2008; Ding et al., 2009).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationNeprilysin−/− mice have enhanced VEGF expression and diminished PEDF expression with no evidence of CNV or leakage on fluorescein angiography.
“The Neprilysin−/− mice have enhanced VEGF expression and diminished PEDF expression with no evidence of CNV or leakage on fluorescein angiography (Yoshida et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yoshida et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationBy 18 months of age, minimal Bruch's membrane thickening, drusen-like sub-RPE deposits, and extensive BlamD and BlinD were observed in mcd/mcd mice.
“By 18 months of age, minimal Bruch’s membrane thickening, drusen-like sub-RPE deposits, and extensive BlamD and BlinD were observed.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rakoczy et al., 2002 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe retina has the highest oxygen consumption of any tissue in the body.
“The retina has the highest oxygen consumption of any tissue in the body (Sickel, 1972).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sickel, 1972 source
Not checked in the free run.
May combine two claims.
PremisecitationAfter 9 months on a high fat/cholesterol diet, 100% of APO*E3 Leiden mice eyes have BlamD, while 33% of APO*E3 Leiden mice on a normal diet have BlamD.
“After 9 months on a high fat/cholesterol diet, 100% of APO*E3 Leiden mice eyes have BlamD, while 33% of APO*E3 Leiden mice on a normal diet have BlamD (Kliffen et al., 2000).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kliffen et al., 2000 source
Not checked in the free run.
May combine two claims.
PremisecitationThe apoB100 transgenic mice have higher serum total and LDL cholesterol and a statistically significant cholesterol-dependent increase in Bruch's membrane thickness.
“The apoB100 transgenic mice have higher serum total and LDL cholesterol and a statistically significant cholesterol-dependent increase in Bruch’s membrane thickness (Sallo et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sallo et al., 2009 source
Not checked in the free run.
May combine two claims.
PremisecitationAt 6-9 months old, Cp−/−Heph−/Y mice had severe retinal degeneration with RPE hypopigmentation, hypertrophy, hyperplasia, and necrosis.
“At 6–9 months old, Cp−/−Heph−/Y mice had severe retinal degeneration with RPE hypopigmentation, hypertrophy, hyperplasia, and necrosis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hahn et al., 2004 source
Not checked in the free run.
May combine two claims.
PremisecitationBy 5-6 months of age, the Cp−/−Heph−/Y mice had increased iron levels, and the highest iron levels were in the RPE and photoreceptor OS.
“By 5–6 months of age, the Cp−/−Heph−/Y mice had increased iron levels, and the highest iron levels were in the RPE and photoreceptor OS.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hahn et al., 2004 source
Not checked in the free run.
May combine two claims.
PremisecitationTight junctions and basal polarity of the RPE nucleus was lost in the mcd2/mcd2 mice.
“Tight junctions and basal polarity of the RPE nucleus was lost in the mcd2/mcd2 mice (Zhang et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zhang et al., 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSmoking is a well-documented AMD risk factor, and a recent meta-analysis showed that current smoking nearly triples AMD incidence.
“Smoking, a common mechanism for generating oxidative stress, is a well-documented AMD risk factor, and a recent meta-analysis showed that current smoking nearly triples AMD incidence (Neuner et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Neuner et al., 2009 source
Not checked in the free run.
May combine two claims.
PremisecitationSod2 knockdown mice had RPE and Bruch's membrane changes and accumulated A2E and lipofuscin granules in the RPE.
“The Sod2 knockdown mice had RPE and Bruch’s membrane changes and accumulated A2E and lipofuscin granules in the RPE (Justilien et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Justilien et al., 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationOn fundoscopic exam at 9 months of age, RPE hypopigmentation, hyperpigmentation, and drusenoid lesions were present in most mcd/mcd mice, while no lesions were present in wild-type mice.
“On fundoscopic exam at 9 months of age, RPE hypopigmentation, hyperpigmentation, and drusenoid lesions were present in most mcd/mcd mice, while no lesions were present in wild-type mice.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rakoczy et al., 2002 source
Not checked in the free run.
May combine two claims.
Premisenone givenAt 6 months, arrd2/arrd2 mice had subnormal rod and cone ERG responses and an undetectable ERG response at 22 months.
“At 6 months, the arrd2/arrd2 mice had subnormal rod and cone ERG responses and an undetectable ERG response at 22 months.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe location of MDM1 on chromosome 12q has previously been reported to be an AMD susceptibility locus.
“though this location has previously been reported to be an AMD susceptibility locus”
Quote in the paperNot a substantial claim0 of 3 sources checkedClassified as probably not a substantial claim.
InterpretationreasoningAs AMD is an age-related phenomenon, the retinas of SAM mice may provide insight into the causes of naturally occurring alterations in the aging human retina.
“As AMD is an age-related phenomenon, the retinas of these mice may provide insight into the causes of naturally occurring alterations in the aging human retina.”
Quote in the paperSubstantial claim- Rests on an assumption: AMD is an age-related phenomenon.
May combine two claims.
PremisecitationThe photoreceptor layer in Mfrprd6 mice degenerates to 33% of its original thickness by 4.5 months of age, 15% of normal by 7 months of age, and becomes 1 cell layer thick by 24 months of age.
“The photoreceptor layer degenerates to 33% of its original thickness by 4.5 months of age, 15% of normal by 7 months of age, and becomes 1 cell layer thick by 24 months of age”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kameya et al., 2002 source
Not checked in the free run.
May combine two claims.
Premisenone givenarrd2/arrd2 mice also have retinal vascular attenuation, RPE hypo-pigmentation and atrophy at 14 months.
“The arrd2/arrd2 mice also have retinal vascular attenuation, RPE hypo-pigmentation and atrophy at 14 months.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenAt 4 months of age, arrd2/arrd2 mice had early photoreceptor outer segment degeneration, increased phagosomes and debris in the RPE, normal ONL, swollen synaptic complexes, and large mitochondria.
“At 4 months of age, the arrd2/arrd2 mice had early photoreceptor outer segment degeneration, increased phagosomes and debris in the RPE, normal ONL, swollen synaptic complexes, and large mitochondria.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenThe inheritance pattern of Nr2e3rd7 is autosomal recessive, and Nr2e3 is mapped to mouse chromosome 9 and human chromosome 15q23.
“The inheritance pattern is autosomal recessive, and Nr2e3 is mapped to mouse chromosome 9 and human chromosome 15q23.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMfrp is expressed at high levels exclusively in the RPE and ciliary epithelium and not the neural retina.
“Mfrp, expressed at high levels exclusively in the RPE and ciliary epithelium and not the neural retina”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Kameya et al., 2002 source
Not checked in the free run.
- cites Xu and Nusse, 1998
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMfrp has strong homology to the cysteine-rich domain of frizzled, a protein that is an important member of the Wnt family of proteins.
“has strong homology to the cysteine-rich domain of frizzled, a protein that is an important member of the Wnt family of proteins”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Kameya et al., 2002 source
Not checked in the free run.
- cites Xu and Nusse, 1998
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe Senescence-Accelerated Mouse (SAM) family is a collection of mouse strains with naturally occurring premature aging and associated pathologies.
“An accelerated aging model, the Senescence-Accelerated Mouse (SAM) family, is a collection of mouse strains with naturally occurring premature aging and associated pathologies”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Takeda, 1997 source
Not checked in the free run.
May combine two claims.
Premisenone givenAt 9 months of age, arrd2/arrd2 mice had fragmented photoreceptor outer segments, abundant phagosomes with loss of the apical processes in the RPE, thinning of the outer plexiform layer (INL and ONL), swollen and necrotic synaptic terminals, and mitochondrial edema.
“At 9 months of age, the arrd2/arrd2 mice had fragmented photoreceptor outer segments, abundant phagosomes with loss of the apical processes in the RPE, thinning of the outer plexiform layer (INL and ONL), swollen and necrotic synaptic terminals, and mitochondrial edema.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenHomozygous Mfrprd6 mice have diminished ERG responses beginning at 1 month of age, supportive of a slow progressive retinal rod and cone dysfunction that culminates in extinguished ERG activity by 70 weeks of age.
“Homozygous Mfrprd6 mice have diminished ERG responses beginning at 1 month of age, supportive of a slow progressive retinal rod and cone dysfunction that culminates in extinguished ERG activity by 70 weeks of age.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRPE cells in CEP-immunized mice had vesiculation, pyknosis, lysis, and areas of RPE loss with overlying swollen photoreceptors.
“The RPE cells in CEP-immunized mice had vesiculation, pyknosis, lysis, and areas of RPE loss with overlying swollen photoreceptors.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hollyfield et al., 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationThe rd6 retinal degeneration is inherited in an autosomal recessive manner and maps to mouse chromosome 9 with a human homolog on chromosome 11q23.
“One of the naturally occurring retinal degeneration and retinitis pigmentosa models, rd6, is inherited in an autosomal recessive manner and maps to mouse chromosome 9 with a human homolog on chromosome 11q23”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hawes et al., 2000
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe first identified retinal degeneration model was RdsRd2, an autosomal dominant slow retinal degeneration identified in inbred mice that accumulated an insertion of foreign DNA into an exon of Rds.
“The first identified retinal degeneration model was RdsRd2, an autosomal dominant slow retinal degeneration identified in inbred mice that accumulated an insertion of foreign DNA into an exon of Rds”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Sanyal and Hawkins, 1986
Not checked in the free run.
- cites van Nie et al., 1978 source
Not checked in the free run.
May combine two claims.
PremisecitationHomozygous Mfrprd6 mice have pan-retinal drusen-like deposits on fundoscopy at 8 weeks of age that progress to advanced retinal degeneration by 8 months of age, and these lesions are associated with macrophage invasion of the sub-retinal space and retinal dysplasia.
“The homozygous Mfrprd6 mice have pan-retinal drusen-like deposits on fundoscopy at 8 weeks of age that progress to advanced retinal degeneration by 8 months of age, and these lesions are associated with macrophage invasion of the sub-retinal space and retinal dysplasia”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hawes et al., 2000
Not checked in the free run.
May combine two claims.
PremisecitationCEP-immunized mice had C3d in Bruch's membrane, signifying that an intact immune system responds to CEP immunization with sub-RPE complement deposition, a feature of AMD.
“Immunized mice had C3d, a C3b degradation product in Bruch’s membrane, signifying that an intact immune system responds to CEP immunization with sub-RPE complement deposition, a well-known feature of AMD”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Hollyfield et al., 2008 source
Not checked in the free run.
- cites Patel and Chan, 2008
Not checked in the free run.
May combine two claims.
PremisecitationThe general structure of the immune system in mice and humans is very similar, though discrepancies in both the innate and adaptive immune system exist.
“The general structure of the immune system in mice and humans is also very similar, though discrepancies in both the innate and adaptive immune system exist”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Premisenone givenHistologic analysis of the photoreceptor ONL in Nr2e3rd7 mice demonstrates retinal dysplasia with whorls and rosettes, which decrease by 5 months of age and disappear when the photoreceptor layer flattens to 5-cell layers thick.
“Histologic analysis of the photoreceptor ONL demonstrates retinal dysplasia with whorls and rosettes, which decrease by 5 months of age and disappear when the photoreceptor layer flattens to 5-cell layers thick.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenGnat2cpfl3 mice have normal rod responses on ERG with an abnormal, significantly reduced, photopic response that was extinguished by 9 months of age.
“Gnat2cpfl3 mice have normal rod responses on ERG with an abnormal, significantly reduced, photopic response that was extinguished by 9 months of age.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSAMP8 mice have a shortened life-span, learning and memory deficits, features of AMD, and no signs of brain atrophy.
“The SAMP8 mice have a shortened life-span, learning and memory deficits, features of AMD, and no signs of brain atrophy”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kawamata et al., 1997 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe described murine models of dry AMD have drusenoid lesions and RPE atrophy on fundoscopy, ERG abnormalities, A2E accumulation, sub-RPE basal deposits, and Bruch's membrane thickening.
“The described murine models of dry AMD have drusenoid lesions and RPE atrophy on fundoscopy, ERG abnormalities, A2E accumulation, sub-RPE basal deposits, and Bruch’s membrane thickening (Table 2).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationBy 25 months of age, SAMR1 mice had near complete loss of the photoreceptor layer peripherally and significant loss of the photoreceptor and ganglion cells centrally.
“By 25 months of age, SAMR1 mice had near complete loss of the photoreceptor layer peripherally and significant loss of the photoreceptor and ganglion cells centrally”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Shoji et al., 1998 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationNr2e3 is part of the cellular and nuclear receptor family for steroid hormones and is involved in cone cell proliferation, maintenance of photoreceptor topography and intercellular interactions, and expression of rod photoreceptor cell-specific genes.
“Nr2e3 is part of the cellular and nuclear receptor family for steroid hormones and is involved in cone cell proliferation, maintenance of photoreceptor topography and intercellular interactions, and expression of rod photoreceptor cell-specific genes”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationThe retinal ultrastructure of Nr2e3rd7 mice demonstrates disorganized photoreceptor outer segments and apical microvilli retardation in the RPE cells.
“The retinal ultrastructure demonstrates disorganized photoreceptor outer segments and apical microvilli retardation in the RPE cells”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Won et al., 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationNr2e3rd7 mice have additional retinal vascular attenuation and mottled retinal pigmentation at 16 months of age.
“There is additional retinal vascular attenuation and mottled retinal pigmentation at 16 months of age”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationIn AMD, cones lose their synaptic connections before dying, and signs of photoreceptor degeneration are found in cones before rods.
“in AMD, cones lose their synaptic connections before dying, and signs of photoreceptor degeneration are found in cones before rods”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shelley et al., 2009 source
Not checked in the free run.
May combine two claims.
Premisenone givenA mutation in exon 6 of Gnat2 results in a missense mutation of the α-subunit of transducin, preventing photoreceptor hyperpolarization in the light transduction cascade, resulting in loss of function in the structurally normal cones in cpfl3/cpfl3 mice.
“A mutation in exon 6 of Gnat2 results in a missense mutation of the α-subunit of transducin, preventing photoreceptor hyperpolarization in the light transduction cascade, resulting loss of function in the structurally normal cones in cpfl3/cpfl3 mice.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenPathologic hallmarks of dry AMD include drusen accumulation (BlamD and BlinD), Bruch's membrane thickening, RPE lipofuscin accumulation followed by degeneration, and photoreceptor degeneration and atrophy.
“Pathologic hallmarks of dry AMD include drusen accumulation (BlamD and BlinD), Bruch’s membrane thickening, RPE lipofuscin accumulation followed by degeneration, and photoreceptor degeneration and atrophy.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe naturally occurring mouse models include retinal degeneration models with mutations in Mdm1, Mfrp, Nr2e3, and Gnat2 with significant photoreceptor pathology and the SAM models with systemic and retinal age-related pathology, including Bruch's membrane thickening, basal deposits, and CNV.
“The naturally occurring mouse models include retinal degeneration models with mutations in Mdm1, Mfrp, Nr2e3, and Gnat2 with significant photoreceptor pathology and the senescence-accelerated mouse (SAM) models with systemic and retinal age-related pathology, including Bruch’s membrane thickening, basal deposits, and CNV.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSAMP mice are short-lived and have double the aging features when compared to the SAMR mice at 8 months of age.
“The SAMP mice are short-lived and have double the aging features when compared to the SAMR mice at 8 months of age”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Premisenone givenFundoscopy of cpfl3/cpfl3 mice shows no retinal lesions and only dilated retinal vessels at 8 months of age.
“Fundoscopy of cpfl3/cpfl3 mice shows no retinal lesions and only dilated retinal vessels at 8 months of age.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningWorking with primates, the only mammals with a macula, may have scientific advantages.
“Working with primates, the only mammals with a macula, may have scientific advantages.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
PremisecitationBlamD, amorphous deposits in the sub-RPE space on the RPE side of Bruch's membrane, were also found in SAM mice.
“BlamD, amorphous deposits in the sub-RPE space on the RPE side of Bruch’s membrane, were also found”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Majji et al., 2000
Not checked in the free run.
May combine two claims.
PremisecitationA mouse with a naturally occurring mutation in cone photoreceptor function loss-3 (cpfl3) is being used as a model for rod monochromism, or achromatopsia, an autosomal recessive disease in which there is a loss of functional retinal cone photoreceptors, resulting in a disease that presents in infancy with horizontal nystagmus, photophobia, color blindness, and poor visual acuity.
“A mouse with a naturally occurring mutation in cone photoreceptor function loss-3 (cpfl3) is being used a model for rod monochromism, or achromatopsia, an autosomal recessive disease in which there is a loss of functional retinal cone photoreceptors, resulting in a disease that presents in infancy with horizontal nystagmus, photophobia, color blindness, and poor visual acuity”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Aligianis et al., 2002 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSequencing of mouse and human genomes reveals great conservation of function and only about 300 unique genes.
“sequencing of mouse and human genomes reveals great conservation of function and only about 300 unique genes”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Waterston et al., 2002 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningWhile the cpfl3 model does not have the Bruch's membrane, RPE, and choriocapillaris changes seen in AMD patients, it demonstrates the cone pathology and dysfunction that can be present in the AMD macula.
“While this model does not have the Bruch’s membrane, RPE, and choriocapillaris changes seen in AMD patients, it demonstrates the cone pathology and dysfunction that can be present in the AMD macula.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAging, or senescence, has been shown to be associated with photoreceptor loss in humans and in murine models.
“Aging, or senescence, has been shown to be associated with photoreceptor loss in humans and in murine models”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Gao and Hollyfield, 1992
Not checked in the free run.
- cites Katz and Robison, 1986
Not checked in the free run.
May combine two claims.
PremisecitationAs SAMP1 and SAMP8 mice age, deposition of fine fibrils in Bruch's membrane increases, resulting in a four-fold increase in thickness of Bruch's membrane by 8 months of age.
“As the SAMP1 and SAMP8 mice age, deposition of fine fibrils in Bruch’s membrane increases, resulting in a four-fold increase in thickness of Bruch’s membrane by 8 months of age”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Takada et al., 1993
Not checked in the free run.
- cites Majji et al., 2000
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenThese models contrast with the murine models of wet AMD that are mostly induced mechanically.
“These models contrast with the murine models of wet AMD that are mostly induced mechanically.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationERGs of homozygous Nr2e3rd7 mice show progressive reduction of both rod and cone signals starting at 5 months of age, and wave amplitudes were 50% of normal by 16 months of age.
“ERGs of homozygous Nr2e3rd7 mice show progressive reduction of both rod and cone signals starting at 5 months of age, and wave amplitudes were 50% of normal by 16 months of age”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Akhmedov et al., 2000 source
Not checked in the free run.
May combine two claims.
PremisecitationThe RPE cells in SAM mice have swelling of basal infoldings and accumulation of lipofuscin granules that increase with age.
“The RPE cells in SAM mice have swelling of basal infoldings and accumulation of lipofuscin granules that increase with age”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ogata et al., 1992
Not checked in the free run.
May combine two claims.
PremisecitationAged primates have macular degeneration that presents in the late 20s with soft drusen and an immunophenotype of drusen very similar to that of humans.
“Aged primates have macular degeneration that presents in the late 20s with soft drusen and an immunophenotype of drusen very similar to that of humans”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Umeda et al., 2005
Not checked in the free run.
May combine two claims.
PremisecitationIn SAMP8 mice, early disruption of the RPE basal microvilli begins at 8 months of age and progresses to severe RPE degeneration by 12 months of age.
“In SAMP8 mice, early disruption of the RPE basal microvilli begins at 8 months of age and progresses to severe RPE degeneration by 12 months of age”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Majji et al., 2000
Not checked in the free run.
May combine two claims.
PremisereasoningThe immunologically manipulated mouse model was immunized against CEP, an endogenous biomarker of oxidative stress, and its phenotype consisted of immune dysregulation and complement deposition as seen in AMD.
“The immunologically manipulated mouse model was immunized against CEP, an endogenous biomarker of oxidative stress, and its phenotype consisted of immune dysregulation and complement deposition as seen in AMD.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTherapies that have been shown to work in mice have failed in human trials, and therapies that do not work in mice have shown success in humans.
“Therapies that have been shown to work in mice have failed in human trials, and therapies that do not work in mice have shown success in humans”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Shepherd and Sridhar, 2003
Not checked in the free run.
- cites Panitch et al., 1987 source
Not checked in the free run.
May combine two claims.
PremisecitationhESC-derived RPE cells were subretinally transplanted into the ELOVL4-mutant mouse and rats with retinal degeneration (RSC rats), followed for >220 days, and shown to recover visual function and photoreceptor integrity without complications.
“human embryonic stem cell (hESC)-derived RPE cells were subretinally transplanted into the ELOVL4-mutant mouse and rats with retinal degeneration (RSC rats). These mice were followed for a prolonged period (>220 days) and shown to recover visual function and photoreceptor integrity without complications”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lu et al., 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningMouse models will likely play a critical role in the future of AMD research, as they may answer many specific questions at the molecular level, potentially providing further insight into the pathogenesis of this disease.
“Mouse models will likely play a critical role in the future of AMD research, as they may answer many specific questions at the molecular level, potentially providing further insight into the pathogenesis of this disease.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe usage of cyclosporine, rapamycin, or daclizumab for uveitis is based on its effectiveness in experimental autoimmune uveitis.
“the usage of cyclosporine, rapamycin, or daclizumab for uveitis is based on its effectiveness in experimental autoimmune uveitis”
Quote in the paperNot a substantial claim0 of 3 sources checked
The paper relies on this without support.
Mice have no macula.
“Although the mouse has no macula, focal atrophy of photorecptors and RPE, lipofuscin accumulation, and increased A2E can develop in aged mouse eyes.”
“The main difference between the human and mouse retina is that the mouse has no maculae.”
The paper relies on this without support.
The mouse retina closely resembles the human nasal and peripheral retina, making mice suitable models for retinal disease.
“mice have been the models for retinal disease because the mouse retina closely resembles the human nasal and peripheral retina”
The paper relies on this without support.
AMD is an age-related phenomenon.
“As AMD is an age-related phenomenon”
The paper relies on this without support.
Mice do not have a macula and lipofuscin extrusion follows a different process.
“Although mice do not have a macula and lipofuscin extrusion follows a different process”
The paper relies on this without support.
AMD is a challenging disease to study because of its complex genetics, late onset, and confounding environmental risk factors.
“AMD is a challenging disease to study because of its complex genetics, late onset, and confounding environmental risk factors.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In RPE-J cells, engulfed POS co-localize with LAMP1, LAMP2, and cathepsin D, indicating that POS degradation proceeds.
“Indeed, we observed that in RPE-J cells engulfed POS co-localized with LAMP1, LAMP2, and cathepsin D (Figure 5A, left panels, arrows) indicating that POS degradation was proceeding (Bosch et al., 1993; Rakoczy et al., 1997; Ramkumar et al., 2010).”
From Noncanonical autophagy promotes the visual cycle (2013) · cites this paper as Ramkumar et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
mcd2/mcd2 mice are compared with themselves
MinorThe paper says mcd2/mcd2 mice developed signs earlier than mcd2/mcd2 mice, although it has just distinguished the new mcd2/mcd2 model from the earlier mcd/mcd model.
“The mcd2/mcd2 mice experienced earlier signs of retinal degeneration than the mcd2/mcd2 mice.”
“To investigate whether the observed phenotype in the mcd/mcd mice is a direct result of the amount of proCatD, a transgenic mouse (mcd2/mcd2) was made with additional deletions in the catD cleavage side such that mcd2/mcd2 mice cannot make any active catD (Zhang et al., 2005).”
Photoreceptor degeneration progresses backward in age
MinorThe passage places thinning at 18 months and says it progressed to marked degeneration by 4 months of age. That reverses the stated progression in time.
“At 18 months of age, the engorged subretinal microglial cells appeared drusen-like on fundoscopy (Combadiere et al., 2007).”
“At this age, the Cx3cr1−/− mice had significant (40%) thinning of the outer retina, mainly the outer nuclear layer, which progressed to marked degeneration of the photoreceptor layer by 4 months of age when compared to wild-type mice.”
SAM strain counts disagree
MinorThe paper describes the SAM family as having 12 lines, but later lists nine senescence-prone and four senescence-resistant strains, totaling 13.
“The Senescence-Accelerated Mouse (SAM) family of 12 murine lines demonstrates accelerated senescence that has been developed by selective inbreeding of the AKR/J strain (Takeda et al., 1994).”
“There are nine senescence-prone inbred strain mice SAMP(1–9) and four senescence-resistant inbred mice SAMR(1–4) (Takeda et al., 1994).”
Cites
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413 · see citing works
Initial sequencing and comparative analysis of the mouse genome
Mouse Genome Sequencing Consortium (2002) · Nature · doi:10.1038/nature01262 · Cited by 7,187 · see citing works
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492 · see citing works
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · see citing works
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822 · see citing works
Prevalence of Age-Related Macular Degeneration in the United States
The Eye Diseases Prevalence Research Group* (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,742 · see citing works
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616 · see citing works
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449 · see citing works
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424 · see citing works
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961 · see citing works
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
Li, Y., Huang, T.-T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-376 · Cited by 1,789 · see citing works
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435 · cited 2× · see citing works
“abcr−/− (Stargardt disease) murine model: Mutations in the human ABCR gene for Rim protein (RmP), a glycoprotein in outer segment disc rims in the ATP-binding cassete (ABC) transporter family, result in the phenotype known as Stargardt’s disease (STGD), a recessive form of macular degeneration that presents in childho…”
BackgroundIdentification of a Gene That Causes Primary Open Angle Glaucoma
Stone, E. M., Fingert, J. H., Alward, W. L. M., Nguyen, T. D., Polansky, J. R., Sunden, S. L. F., Nishimura, D. Y., Clark, A. F., Nystuen, A., Nichols, B. E., et al. (1997) · Science · doi:10.1126/science.275.5300.668 · Cited by 1,432 · see citing works
The Major Cell Populations of the Mouse Retina
Jeon, C.-J., Strettoi, E., & Masland, R. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-21-08936.1998 · Cited by 1,429 · see citing works
The matrix‐degrading metalloproteinases
Matrisian, L. M. (1992) · BioEssays · doi:10.1002/bies.950140705 · Cited by 1,375 · see citing works
Drusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208 · see citing works
A role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087 · see citing works
Vulpe, C. D., Kuo, Y.-M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., Gitschier, J., & Anderson, G. J. (1999) · Nature Genetics · doi:10.1038/5979 · Cited by 1,084 · see citing works
The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1750 · Cited by 1,075 · see citing works
Exacerbations of multiple sclerosis in patients treated with gamma interferon
Panitch, H., Haley, A., Hirsch, R., & Johnson, K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92863-7 · Cited by 1,071 · see citing works
Lu, B., RUTLEDGE, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R. J., Gerard, C. J., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017 · see citing works
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937 · see citing works
Metabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N., Gerard, C., Hama, E., Lee, H., & Saido, T. (2001) · Science · doi:10.1126/science.1059946 · Cited by 894 · see citing works
Ageing and degeneration in the macular region: A clinico-pathological study
Sarks, S. H. (1976) · British Journal of Ophthalmology · doi:10.1136/bjo.60.5.324 · Cited by 891 · see citing works
Weng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G., & Travis, G. H. (1999) · Cell · doi:10.1016/s0092-8674(00)80602-9 · Cited by 881 · cited 10× · see citing works
“ELOVL4 is normally heavily expressed in the endoplasmic reticulum of rod and cone photoreceptor cells; however, mutant ELOV4 acts as a dominant negative protein (Vasireddy et al., 2005) and loses its ER retention signal, causing deranged intercellular trafficking and accumulation of mutant ELOV4 in the Golgi apparatus…”
BackgroundResultInfluentialRetinal degeneration mutants in the mouse
Chang, B., Hawes, N. L., Hurd, R. E., Davisson, M. T., Nusinowitz, S., & Heckenlively, J. R. (2002) · Vision Research · doi:10.1016/s0042-6989(01)00146-8 · Cited by 840 · see citing works
Photoreceptor loss in age-related macular degeneration.
Curcio, C. A., Medeiros, N. E., & Millican, C. L. (1996) · PubMed · Cited by 802 · see citing works
COPPER-ZINC SUPEROXIDE DISMUTASE AND AMYOTROPHIC LATERAL SCLEROSIS
Valentine, J. S., Doucette, P. A., & Potter, S. Z. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161647 · Cited by 790 · see citing works
Age-related Macular Degeneration Histopathologic Studies
Green, W. R., & Enger, C. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31466-1 · Cited by 757 · see citing works
Pitas, R. E., Boyles, J. K., Lee, S. H., Hui, D., & Weisgraber, K. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47945-8 · Cited by 714 · see citing works
Oxidative damage-induced inflammation initiates age-related macular degeneration
Hollyfield, J. G., Bonilha, V. L., Rayborn, M. E., Yang, X., Shadrach, K. G., Lu, L., Ufret, R. L., Salomon, R. G., & Perez, V. L. (2008) · Nature Medicine · doi:10.1038/nm1709 · Cited by 710 · see citing works
Kuziel, W. A., Morgan, S. J., Dawson, T. C., Griffin, S., Smithies, O., Ley, K. F., & Maeda, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12053 · Cited by 709 · see citing works
Rods and cones in the mouse retina. I. Structural analysis using light and electron microscopy
Carter‐Dawson, L. D., & LaVail, M. M. (1979) · The Journal of Comparative Neurology · doi:10.1002/cne.901880204 · Cited by 695 · see citing works
Para-Inflammation in the Aging Retina
Xu, H., Chen, M., & Forrester, J. V. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.06.001 · Cited by 659 · see citing works
Weber, B. H. F., Vogt, G., Pruett, R. C., Stöhr, H., & Felbor, U. (1994) · Nature Genetics · doi:10.1038/ng1294-352 · Cited by 656 · see citing works
Wenzel, A., Grimm, C., Samardzija, M., & Remé, C. E. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.08.002 · Cited by 648 · see citing works
Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts
Gehrs, K. M., Anderson, D. H., Johnson, L. V., & Hageman, G. S. (2006) · Annals of Medicine · doi:10.1080/07853890600946724 · Cited by 633 · see citing works
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice
Ambati, J., Anand, A., Fernandez, S., Sakurai, E., Lynn, B. C., Kuziel, W. A., Rollins, B. J., & Ambati, B. K. (2003) · Nature Medicine · doi:10.1038/nm950 · Cited by 631 · see citing works
Combadière, C., Feumi, C., Raoul, W., Keller, N., Rodéro, M., Pézard, A., Lavalette, S., Houssier, M., Jonet, L., Picard, E., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31692 · Cited by 618 · cited 3× · see citing works
“Homozygosity of the CX3CR1 M280 allele and V249I allele, associated with impaired microglial cell migration, has been shown to increase the risk of AMD (Combadiere et al., 2007; Tuo et al., 2004).”
Background(1992) · PubMed · Cited by 604 · see citing works
Maller, J., George, S., Purcell, S., Fagerness, J., Altshuler, D., Daly, M. J., & Seddon, J. M. (2006) · Nature Genetics · doi:10.1038/ng1873 · Cited by 599 · see citing works
Molecular pathology of age-related macular degeneration
Ding, X., Patel, M., & Chan, C.-C. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.10.001 · Cited by 582 · cited 8× · see citing works
“The molecular pathology of dry AMD has demonstrated a role of oxidative stress, inflammation, and metabolic dysregulation (Ding et al. 2009).”
BackgroundInfluentialSelf-citationSullivan, P. M., Mezdour, H., Aratani, Y., Knouff, C., Najib, J., Reddick, R. L., Quarfordt, S. H., & Maeda, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17972 · Cited by 575 · see citing works
Age-related macular degeneration
Coleman, H. R., Chan, C.-C., Ferris, F. L., & Chew, E. Y. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61759-6 · Cited by 542 · see citing works
Self-citationHaider, N. B., Jacobson, S. G., Cideciyan, A. V., Swiderski, R., Streb, L. M., Searby, C., Beck, G., Hockey, R., Hanna, D. B., Gorman, S., et al. (2000) · Nature Genetics · doi:10.1038/72777 · Cited by 507 · see citing works
Genetic Association of Apolipoprotein E with Age-Related Macular Degeneration
Klaver, C. C. W., Kliffen, M., van Duijn, C. M., Hofman, A., Cruts, M., Grobbee, D. E., van Broeckhoven, C., & de Jong, P. T. V. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301901 · Cited by 498 · see citing works
Fibulins: a versatile family of extracellular matrix proteins
Timpl, R., Sasaki, T., Kostka, G., & Chu, M.-L. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1130 · Cited by 494 · see citing works
Stone, E. M., Lotery, A. J., Munier, F. L., Héon, E., Piguet, B., Guymer, R. H., Vandenburgh, K., Cousin, P., Nishimura, D. Y., Swiderski, R. E., et al. (1999) · Nature Genetics · doi:10.1038/9722 · Cited by 488 · see citing works
A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase
Melov, S., Schneider, J. A., Day, B. J., Hinerfeld, D. A., Coskun, P. E., Mirra, S. S., Crapo, J. D., & Wallace, D. C. (1998) · Nature Genetics · doi:10.1038/ng0298-159 · Cited by 487 · see citing works
(2011) · SpringerReference · doi:10.1007/springerreference_36603 · Cited by 486 · see citing works
Lü, B., Malcuit, C. M., Wang, S., Girman, S. V., Francis, P. J., Lemieux, L., Lanza, R., & Lund, R. D. (2009) · Stem Cells · doi:10.1002/stem.149 · Cited by 471 · see citing works
Zhang, K., Kniazeva, M., Han, M., Li, W., Yu, Z., Yang, Z., Li, Y., Metzker, M. L., Allikmets, R. L., Zack, D. J., et al. (2001) · Nature Genetics · doi:10.1038/83817 · Cited by 453 · see citing works
Johnson, L. V., Leitner, W. P., Rivest, A. J., Staples, M. K., Radeke, M. J., & Anderson, D. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192203399 · Cited by 447 · see citing works
Seddon, J. M. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.3.321 · Cited by 446 · cited 1× · see citing works
“When one or both twins have AMD, concordance is 55% among monozygotic twins and 25% among dizygotic twins for AMD (Seddon et al., 2005).”
BackgroundAccumulation of cholesterol with age in human Bruch's membrane.
Curcio, C. A., Millican, C. L., Bailey, T. A., & Kruth, H. S. (2001) · PubMed · Cited by 442 · see citing works
Imamura, Y., Noda, S., Hashizume, K., Shinoda, K., Yamaguchi, M., Uchiyama, S., Shimizu, T., Mizushima, Y., Shirasawa, T., & Tsubota, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602131103 · Cited by 420 · see citing works
Aging changes in Bruch's membrane. A histochemical and morphologic study.
Pauleikhoff, D., Harper, C. A., Marshall, J., & Bird, A. C. (1990) · PubMed · Cited by 401 · see citing works
Sunlight and Age-Related Macular Degeneration
Cruickshanks, K. J. (1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090040106042 · Cited by 401 · see citing works
Basal Linear Deposit and Large Drusen Are Specific for Early Age-Related Maculopathy
Curcio, C. A. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.3.329 · Cited by 388 · see citing works
Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury
Patel, B. N., Dunn, R. J., Jeong, S. Y., Zhu, Q., Julien, J.-P., & David, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06578.2002 · Cited by 379 · see citing works
Association Between C-Reactive Protein and Age-Related Macular Degeneration
Keenan, T. D. L., & Chew, E. Y. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2210 · Cited by 378 · see citing works
Association between C-reactive protein and age-related macular degeneration
Seddon, J. M. (2004) · JAMA · doi:10.1001/jama.291.6.704 · Cited by 376 · see citing works
DSPP mutation in dentinogenesis imperfecta Shields type II
Zhang, X., Zhao, J. L., Li, C., Gao, S., Qiu, C., Liu, P., Wu, G., Qiang, B., Lo, W. H. Y., & Shen, Y. (2001) · Nature Genetics · doi:10.1038/84765 · Cited by 370 · see citing works
Distribution of photoreceptor subtypes in the retina of diurnal and nocturnal primates
Wikler, K., & RAKIC, P. T. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03390.1990 · Cited by 356 · see citing works
Species differences in the structure and function of the immune system
Haley, P. J. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00043-x · Cited by 336 · see citing works
Senescence-accelerated mouse (SAM): a novel murine model of senescence
Takeda, T., Hosokawa, M., & Higuchi, K. (1997) · Experimental Gerontology · doi:10.1016/s0531-5565(96)00036-8 · Cited by 332 · see citing works
Patel, B. N., & David, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20185 · Cited by 327 · see citing works
Gu, X., Meer, S. G., Miyagi, M., Rayborn, M. E., Hollyfield, J. G., Crabb, J. W., & Salomon, R. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305460200 · Cited by 326 · see citing works
Missense Variations in the Fibulin 5 Gene and Age-Related Macular Degeneration
Stone, E. M., Braun, T. A., Russell, S. R., Kuehn, M. H., Lotery, A. J., Moore, P. A., Eastman, C. G., Casavant, T. L., & Sheffield, V. C. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040833 · Cited by 324 · see citing works
Aging Changes in Bruch's Membrane
Pauleikhoff, D., Harper, C. A., Marshall, J., & Bird, A. C. (1990) · Ophthalmology · doi:10.1016/s0161-6420(90)32619-2 · Cited by 322 · see citing works
Anderson, D. H., Talaga, K. C., Rivest, A. J., Barron, E., Hageman, G. S., & Johnson, L. V. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2003.10.011 · Cited by 319 · see citing works
Histopathology of Age-Related Macular Degeneration
Lim, J. I. (2007) · CRC Press eBooks · doi:10.3109/9781420019865-6 · Cited by 310 · see citing works
Unique topographic separation of two spectral classes of cones in the mouse retina
Szél, Á., Röhlich, P., Gaffé, A. R., Juliusson, B., Aguirre, G. K., & Veen, T. V. (1992) · The Journal of Comparative Neurology · doi:10.1002/cne.903250302 · Cited by 301 · see citing works
The epidemiology of age related eye diseases in Asia
Wong, T. Y. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.083733 · Cited by 301 · see citing works
Age-related variation in the hydraulic conductivity of Bruch's membrane.
Moore, D., Hussain, A., & Marshall, J. (1995) · PubMed · Cited by 288 · see citing works
Über familiäre, progressive Degeneration in der Maculagegend des Auges
Stargardt, K. (1909) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf01961301 · Cited by 287 · see citing works
Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration
Malek, G., Johnson, L. V., Mace, B. E., Saloupis, P., Schmechel, D. E., Rickman, D. W., Toth, C. A., Sullivan, P. M., & Rickman, C. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503015102 · Cited by 284 · see citing works
Xu, H., Chen, M., Manivannan, A., Lois, N., & Forrester, J. V. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2007.00351.x · Cited by 277 · see citing works
Tsutsumi, C., Sonoda, K.-H., Egashira, K., Qiao, H., Hisatomi, T., Nakao, S., Ishibashi, M., Charo, I. F., Sakamoto, T., Murata, T., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0902436 · Cited by 277 · see citing works
Do age-related macular degeneration and cardiovascular disease share common antecedents?
Snow, K. K., & Seddon, J. M. (1999) · Ophthalmic Epidemiology · doi:10.1076/opep.6.2.125.1558 · Cited by 275 · see citing works
PARTICIPATION OF THE RETINAL PIGMENT EPITHELIUM IN THE ROD OUTER SEGMENT RENEWAL PROCESS
Young, R. W., & Bok, D. (1969) · Journal of Cell Biology · doi:10.1083/jcb.42.2.392 · Cited by 271 · see citing works
Cheng, H. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh173 · Cited by 268 · see citing works
Hahn, P., Qian, Y., Dentchev, T., Chen, L., Beard, J., Harris, Z. L., & Dunaief, J. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405146101 · Cited by 264 · see citing works
Iron homeostasis and toxicity in retinal degeneration
He, X., Hahn, P., Iacovelli, J., Wong, R., King, C., Bhisitkul, R., Massaro-Giordano, M., & Dunaief, J. L. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2007.07.004 · Cited by 260 · see citing works
Hahn, P. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.8.1099 · Cited by 258 · see citing works
Dentchev, T., Milam, A. H., Lee, V. M. ‐., Trojanowski, J. Q., & Dunaief, J. L. (2003) · PubMed · Cited by 252 · see citing works
Age-related Macular Degeneration: Clinical Features in a Large Family and Linkage to Chromosome 1q
Klein, M. L. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.8.1082 · Cited by 252 · see citing works
Anderson, R. E. (1970) · Experimental Eye Research · doi:10.1016/s0014-4835(70)80046-x · Cited by 248 · see citing works
Age-Related Macular Degeneration and Smoking: The Rotterdam Study
Vingerling, J. R. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140393005 · Cited by 246 · see citing works
Meta-analysis of genome scans of age-related macular degeneration
Fisher, S. A., Abecasis, G. R., Yashar, B. M., Zareparsi, S., Swaroop, A., Iyengar, S. K., Klein, B. E. K., Klein, R., Lee, K. E., Majewski, J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi230 · Cited by 239 · see citing works
SOD2 knockdown mouse model of early AMD
Justilien, V., Pang, J.-J., Renganathan, K., Zhan, X., Crabb, J. W., Kim, S. R., Sparrow, J. R., Hauswirth, W. W., & Lewin, A. S. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0432 · Cited by 234 · see citing works
Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction
Coffey, P. J., Gias, C., McDermott, C. J., Lundh, P., Pickering, M. C., Sethi, C., Bird, A., Fitzke, F. W., Maass, A., Chen, L. L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705079104 · Cited by 231 · see citing works
Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia
van den Maagdenberg, A. M. J. M., Hofker, M. H., Krimpenfort, P., de Bruijn, I., van Vlijmen, B. J. M., van der Boom, H., Havekes, L. M., & Frants, R. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82232-3 · Cited by 229 · see citing works
Sorsby, A., Mason, M. E. J., & Gardener, N. (1949) · British Journal of Ophthalmology · doi:10.1136/bjo.33.2.67 · Cited by 224 · see citing works
Johnson, P. T., Betts, K. E., Radeke, M. J., Hageman, G. S., Anderson, D. H., & Johnson, L. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606234103 · Cited by 223 · see citing works
Akhmedov, N. B., Piriev, N. I., Chang, B., Rapoport, A. L., Hawes, N. L., Nishina, P. M., Nusinowitz, S., Heckenlively, J. R., Roderick, T. H., Kozak, C. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5551 · Cited by 221 · see citing works
Mata, N. L., Tzekov, R. T., Liu, X., Weng, J., Birch, D. G., & Travis, G. H. (2001) · PubMed · Cited by 219 · see citing works
Tuo, J., Smith, B. C., Bojanowski, C. M., Meleth, A. D., Gery, I., Csaky, K. G., Chew, E. Y., & Chan, C.-C. (2004) · The FASEB Journal · doi:10.1096/fj.04-1862fje · Cited by 215 · see citing works
Self-citationRetinal photoreceptor density decreases with age
Panda-Jonas, S., Jonas, J. B., & Jakobczyk-Zmija, M. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30784-1 · Cited by 208 · see citing works
Tuo, J., Bojanowski, C. M., Zhou, M., Shen, D., Ross, R. J., Rosenberg, K. I., Cameron, D. J., Yin, C., Kowalak, J. A., Zhuang, Z., et al. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0051 · Cited by 205 · see citing works
Self-citationRegion‐specific reduction of Aβ‐degrading endopeptidase, neprilysin, in mouse hippocampus upon aging
Iwata, N., Takaki, Y., Fukami, S., Tsubuki, S., & Saido, T. C. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10390 · Cited by 203 · see citing works
The potential role of amyloid in the pathogenesis of age-related macular degeneration
Yoshida, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24635 · Cited by 202 · see citing works
Haider, N. B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.16.1619 · Cited by 202 · cited 3× · see citing works
“Nr2e3 is part of the cellular and nuclear receptor family for steroid hormones and is involved in cone cell proliferation, maintenance of photoreceptor topography and intercellular interactions, and expression of rod photoreceptor cell-specific genes (Fuller, 1991; Haider et al., 2001; Cheng et al., 2004).”
BackgroundThe 2 and 4 Alleles of the Apolipoprotein Gene Are Associated with Age-Related Macular Degeneration
Baird, P. N. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1121 · Cited by 201 · see citing works
The steroid receptor superfamily: mechanisms of diversity
Fuller, P. J. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.15.1743440 · Cited by 200 · see citing works
The Inheritance of a Retinal Abnormality in White Mice
Keeler, C. E. (1924) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.10.7.329 · Cited by 197 · see citing works
Purcell-huynh, D. A., Farese, R. V., Johnson, D. F., Flynn, L. M., Pierotti, V., Newland, D., Linton, M. F., Sanan, D. A., & Young, S. G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117915 · Cited by 197 · see citing works
Ceruloplasmin gene expression in the murine central nervous system.
Klomp, L. W. J., Farhangrazi, Z. S., Dugan, L. L., & Gitlin, J. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118768 · Cited by 194 · see citing works
A New H‐2‐Linked Mutation, <i>rds</i> , Causing Retinal Degeneration in the Mouse
van Nie, R., Iványi, D., & Démant, P. (1978) · Tissue Antigens · doi:10.1111/j.1399-0039.1978.tb01305.x · Cited by 191 · see citing works
Histologic Features of the Early Stages of Age-related Macular Degeneration
van der Schaft, T. L., Mooy, C. M., de Bruijn, W. C., Oron, F. G., Mulder, P. G. H., & de Jong, P. T. V. M. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)31982-7 · Cited by 186 · see citing works
Biology of Aβ Amyloid in Alzheimer's Disease
Wısnıewskı, T., Ghiso, J. A., & Frangione, B. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0147 · Cited by 185 · see citing works
Visual function and dysfunction in early and late age-related maculopathy
Hogg, R. E., & Chakravarthy, U. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2005.11.002 · Cited by 183 · see citing works
Espinosa‐Heidmann, D. G., Suñer, I. J., Catanuto, P., Hernandez, E. P., Marin‐Castaño, M. E., & Cousins, S. W. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0719 · Cited by 183 · see citing works
Karan, G., Lillo, C., Yang, Z., Cameron, D. J., Locke, K. G., Zhao, Y., Thirumalaichary, S., Li, C., Birch, D. G., Vollmer-Snarr, H. R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407698102 · Cited by 182 · see citing works
Superoxide dismutase isoenzymes in the human eye.
Behndig, A., Svensson, B., Marklund, S. L., & Karlsson, K. (1998) · PubMed · Cited by 174 · see citing works
Iyengar, S. K., Song, D., Klein, B. E. K., Klein, R., Schick, J. H., Humphrey, J., Millard, C., Liptak, R., Russo, K., Jun, G., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/380912 · Cited by 173 · cited 1× · see citing works
“Analysis of a cohort of AMD patients with the human ortholog of MDM1 on chromosome 12q did not reveal an association between MDM1 and AMD, though this location has previously been reported to be an AMD susceptibility locus (Chang et al., 2008; Iyengar et al., 2004; Fisher et al., 2005).”
BackgroundRakoczy, P. E., Zhang, D., Robertson, T., Barnett, N. L., Papadimitriou, J., Constable, I. J., & Lai, C.-M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64427-6 · Cited by 173 · see citing works
Swaroop, A., Branham, K. E., Chen, W., & Abecasis, G. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm212 · Cited by 173 · see citing works
Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice.
Dithmar, S., Curcio, C. A., Le, N., Brown, S., & Grossniklaus, H. E. (2000) · PubMed · Cited by 171 · see citing works
Inflammation, the complement system and the diseases of aging
McGeer, E. G., Klegeris, A., & McGeer, P. L. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.008 · Cited by 170 · see citing works
Hydrodynamics of ageing Bruch’s membrane: Implications for macular disease
STARITA, C., HUSSAIN, A. A., PAGLIARINI, S., & MARSHALL, J. (1996) · Experimental Eye Research · doi:10.1006/exer.1996.0066 · Cited by 170 · see citing works
Stone, E. M. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090180063036 · Cited by 169 · see citing works
Spraul, C. W. (1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100150269022 · Cited by 168 · see citing works
Hephaestin is a ferroxidase that maintains partial activity in sex-linked anemia mice
Chen, H. (2004) · Blood · doi:10.1182/blood-2003-09-3139 · Cited by 165 · see citing works
Immunopathological aspects of age-related macular degeneration
Patel, M. M., & Chan, C. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0112-9 · Cited by 163 · see citing works
Self-citationUmeda, S., SUZUKI, M. T., Okamoto, H., Ono, F., Mizota, A., Terao, K., Yoshikawa, Y., Tanaka, Y., & Iwata, T. (2005) · The FASEB Journal · doi:10.1096/fj.04-3525fje · Cited by 163 · see citing works
Granulomatous reaction to Bruch's membrane in age-related macular degeneration
Dastgheib, K. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090180111045 · Cited by 162 · see citing works
Klomp, L. W. J. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.12.1989 · Cited by 161 · see citing works
Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice
McLaughlin, P. J., Bakall, B., Choi, J., Liu, Z., Sasaki, T., Davis, E. C., Marmorstein, A. D., & Marmorstein, L. Y. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm264 · Cited by 160 · see citing works
Chang, B., Dacey, M. S., Hawes, N. L., Hitchcock, P. F., Milam, A. H., Atmaca-Sonmez, P., Nusinowitz, S., & Heckenlively, J. R. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1468 · Cited by 157 · see citing works
Prevalence of Age-related Maculopathy in the Atherosclerosis Risk in Communities Study
Klein, R. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.9.1203 · Cited by 154 · see citing works
Animal models in research on retinal degenerations: past progress and future hope
Chader, G. J. (2002) · Vision Research · doi:10.1016/s0042-6989(01)00212-7 · Cited by 147 · see citing works
Feeney-Burns, L., & Ge, E. (1983) · PubMed · Cited by 143 · see citing works
Mouse fundus photography and angiography: a catalogue of normal and mutant phenotypes.
Hawes, N. L., Smith, R. S., Chang, B., Davisson, M. T., Heckenlively, J. R., & John, S. W. M. (1999) · PubMed · Cited by 143 · see citing works
The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice
Fu, L., Garland, D. L., Yang, Z., Shukla, D., Rajendran, A., Pearson, E., Stone, E. M., Zhang, K., & Pierce, E. A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm198 · Cited by 142 · see citing works
Alzheimer’s Disease as Proteolytic Disorders: Anabolism and Catabolism of β-Amyloid
Saido, T. C. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00033-5 · Cited by 140 · see citing works
Mfrp, a gene encoding a frizzled related protein, is mutated in the mouse retinal degeneration 6
Kameya, S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.16.1879 · Cited by 134 · see citing works
Aligianis, I. A., Forshew, T., Johnson, S., Michaelides, M., Johnson, C. A., Trembath, R. C., Hunt, D. M., Moore, A. T., & Maher, E. R. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.9.656 · Cited by 130 · see citing works
The Frizzled CRD domain is conserved in diverse proteins including several receptor tyrosine kinases
Xu, Y. K., & Nusse, R. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70262-3 · Cited by 129 · see citing works
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
Patel, N., Ohbayashi, M., Nugent, A. K., Ramchand, K., Toda, M., Chau, K., Bunce, C., Webster, A., Bird, A. C., Ono, S. J., et al. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02173.x · Cited by 125 · see citing works
A novel murine model of aging, Senescence-Accelerated Mouse (SAM)
Takeda, T., Hosokawa, M., Higuchi, K., Hosono, M., Akiguchi, I., & Katoh, H. (1994) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(94)90039-6 · Cited by 122 · see citing works
Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD
Hadziahmetovic, M., Dentchev, T., Song, Y., Haddad, N., He, X., Hahn, P., Pratico, D., Wen, R., Harris, Z. L., Lambris, J. D., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1472 · Cited by 121 · see citing works
Marmorstein, L. Y., McLaughlin, P. J., Peachey, N. S., Sasaki, T., & Marmorstein, A. D. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm199 · Cited by 119 · see citing works
Ebrahem, Q., Renganathan, K., Sears, J., Vasanji, A., Gu, X., Lu, L., Salomon, R. G., Crabb, J. W., & Anand-Apte, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601552103 · Cited by 117 · see citing works
KIM, S. Y., SADDA, S., HUMAYUN, M. S., de JUAN, E., MELIA, B. M., & GREEN, W. R. (2002) · Retina · doi:10.1097/00006982-200208000-00011 · Cited by 117 · see citing works
Hogan, M. J. (1967) · Archives of Ophthalmology · doi:10.1001/archopht.1967.00980020412022 · Cited by 116 · see citing works
Evidence of cell loss from the rat retina during senescence
Katz, M. L., & Robison, W. G. (1986) · Experimental Eye Research · doi:10.1016/0014-4835(86)90022-9 · Cited by 115 · see citing works
Amyloid‐β(1‐42) alters structure and function of retinal pigmented epithelial cells
Bruban, J., Glotin, A., Dinet, V., Chalour, N., Sennlaub, F., Jonet, L., An, N., Faussat, A. M., & Mascarelli, F. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00456.x · Cited by 114 · see citing works
Farkas, T. G., Sylvester, V., Archer, D., & Altona, M. (1971) · American Journal of Ophthalmology · doi:10.1016/0002-9394(71)90964-0 · Cited by 112 · see citing works
Cerebral amyloid angiopathy: Pathogenesis and effects on the ageing and Alzheimer brain
Weller, R. O., & Nicoll, J. A. R. (2003) · Neurological Research · doi:10.1179/016164103101202057 · Cited by 112 · see citing works
Overview of progress in the epidemiology of age-related macular degeneration
Klein, R. (2007) · Ophthalmic Epidemiology · doi:10.1080/09286580701344381 · Cited by 110 · see citing works
Retinal degeneration 6 (rd6): a new mouse model for human retinitis punctata albescens.
Hawes, N. L., Chang, B., Hageman, G. S., Nusinowitz, S., Nishina, P. M., Schneider, B. S., Smith, R. S., Roderick, T. H., Davisson, M. T., & Heckenlively, J. R. (2000) · PubMed · Cited by 109 · see citing works
Cousins, S. W., Espinosa‐Heidmann, D. G., Αλεξανδρίδου, Α., Sall, J. C., Dubovy, S. R., & Csaky, K. G. (2002) · Experimental Eye Research · doi:10.1006/exer.2002.2047 · Cited by 107 · see citing works
Mouse models of age-related macular degeneration
Elizabeth Rakoczy, P., Yu, M. J. T., Nusinowitz, S., Chang, B., & Heckenlively, J. R. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.10.012 · Cited by 107 · see citing works
Heckenlively, J. R., Chang, B., Erway, L. C., Peng, C., Hawes, N. L., Hageman, G. S., & Roderick, T. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11100 · Cited by 106 · see citing works
Retina-derived microglial cells induce photoreceptor cell death in vitro
Roque, R. S., Rosales, A. A., Jingjing, L., Agarwal, N., & Al-Ubaidi, M. R. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01625-x · Cited by 101 · see citing works
Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4
Enzinger, C., Ropele, S., Smith, S. M., Strasser‐Fuchs, S., Poltrum, B., Schmidt, H., Matthews, P. M., & Fazekas, F. (2004) · Annals of Neurology · doi:10.1002/ana.20027 · Cited by 100 · see citing works
The proteome of central and peripheral retina with progression of age-related macular degeneration
Ethen, C. M., Reilly, C., Feng, X., Olsen, T. W., & Ferrington, D. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1395 · Cited by 99 · see citing works
<i>Ccl2/Cx3cr1-</i>Deficient Mice: An Animal Model for Age-Related Macular Degeneration
Chan, C.-C., Ross, R. J., Shen, D., Ding, X., Majumdar, Z., Bojanowski, C. M., Zhou, M., Salem, Jr., Bonner, R., & Tuo, J. (2008) · Ophthalmic Research · doi:10.1159/000119862 · Cited by 98 · see citing works
Self-citationA mouse model for Sorsby fundus dystrophy
Weber, B. H. F., Lin, B., White, K., Köhler, K., Soboleva, G. M., Herterich, S., Seeliger, M. W., Jaissle, G. B., Grimm, C., Remé, C., et al. (2002) · PubMed · doi:10.5283/epub.35828 · Cited by 87 · see citing works
Strohmeyer, R., Ramirez, M., Cole, G. J., Mueller, K., & Rogers, J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00272-2 · Cited by 87 · see citing works
Alsenz, J., Schulz, T. F., Lambris, J. D., Sim, R. B., & Dierich, M. P. (1985) · Biochemical Journal · doi:10.1042/bj2320841 · Cited by 87 · see citing works
Cone degeneration in aging and age-related macular degeneration
Shelley, E. J. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2008.622 · Cited by 85 · see citing works
Increased expression of ceruloplasmin in the retina following photic injury.
Chen, L., Dentchev, T., Wong, R., Hahn, P., Wen, R., Bennett, J., & Dunaief, J. L. (2003) · PubMed · Cited by 84 · see citing works
Espinosa‐Heidmann, D. G., Sall, J. C., Hernandez, E. P., & Cousins, S. W. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0910 · Cited by 82 · see citing works
Murine High-Fat Diet and Laser Photochemical Model of Basal Deposits in Bruch Membrane
Dithmar, S. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.11.1643 · Cited by 81 · see citing works
Uchihara, T., Akiyama, H., Kondo, H., & Ikeda, K. (1997) · Stroke · doi:10.1161/01.str.28.10.1948 · Cited by 81 · see citing works
A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration
Tuo, J., Ross, R. J., Herzlich, A. A., Shen, D., Ding, X., Zhou, M., Coon, S. L., Hussein, N., Salem, N., & Chan, C.-C. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090089 · Cited by 80 · see citing works
Self-citationTIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.
Chong, V. N., Alexander, R., Gin, T., Bird, A. C., & Luthert, P. J. (2000) · PubMed · Cited by 78 · see citing works
C-reactive Protein Level and Risk of Aging Macula Disorder
Boekhoorn, S. S. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.10.1396 · Cited by 78 · see citing works
Mouse models of ocular diseases
Chang, B., Hawes, N. L., Hurd, R. E., Wang, J., Howell, D., Davisson, M. T., Roderick, T. H., Nusinowitz, S., & Heckenlively, J. R. (2005) · Visual Neuroscience · doi:10.1017/s0952523805225075 · Cited by 75 · see citing works
Female Gender, Estrogen Loss, and Sub-RPE Deposit Formation in Aged Mice
Cousins, S. W., Marin-Castan~o, M. E., Espinosa‐Heidmann, D. G., Alexandridou, A., Striker, L. J., & Elliot, S. J. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0285 · Cited by 74 · see citing works
Sanyal, S., & Hawkins, R. K. (1986) · Vision Research · doi:10.1016/0042-6989(86)90099-4 · Cited by 73 · see citing works
Bench to bedside: new approaches to the immunotherapy of uveitic disease
NUSSENBLATT, R. B. (2002) · International Reviews of Immunology · doi:10.1080/08830180212067 · Cited by 72 · see citing works
Kawamata, T. (1997) · Experimental Gerontology · doi:10.1016/s0531-5565(96)00063-0 · Cited by 72 · see citing works
The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit
Kliffen, M. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.12.1415 · Cited by 71 · see citing works
Ocular pathology in mitochondrial superoxide dismutase (Sod2)-deficient mice.
Sandbach, J., Coscun, P. E., GROSSNIKLAUS, H. E., Kokoszka, J. E., Newman, N. J., & Wallace, D. C. (2001) · PubMed · Cited by 68 · see citing works
Francis, P. J., Zhang, H., DeWan, A. T., Hoh, J. J., & Klein, M. L. (2008) · PubMed Central · Cited by 65 · see citing works
Modulation of cathepsin D activity in retinal pigment epithelial cells
RAKOCZY, P. E., LAI, C. M., BAINES, M., GRANDI, S. D., FITTON, J. H., & CONSTABLE, I. J. (1997) · Biochemical Journal · doi:10.1042/bj3240935 · Cited by 64 · see citing works
Martin, D. F., DeBarge, L. R., Nussenblatt, R. B., Chan, C. C., & Roberge, F. G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.2.922 · Cited by 63 · cited 2× · see citing works
“in experimental autoimmune uveitis (Nussenblatt, 2002; Martin et al., 1995; Nussenblatt et al., 1983).”
BackgroundSelf-citationCholesterol at the crossroads: Alzheimer's disease and lipid metabolism
Wellington, C. L. (2004) · Clinical Genetics · doi:10.1111/j.0009-9163.2004.00280.x · Cited by 62 · see citing works
Fujihara, M., Bartels, E. D., Nielsen, L. B., & Handa, J. T. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.01.017 · Cited by 62 · see citing works
Bojanowski, C. M., Shen, D., Chew, E. Y., Ning, B., Csaky, K. G., Green, W. R., Chan, C., & Tuo, J. (2006) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20233 · Cited by 62 · see citing works
Self-citationElovl4 5-bp–Deletion Knock-in Mice Develop Progressive Photoreceptor Degeneration
Vasireddy, V., Jablonski, M. M., Mandal, M. N. A., Raz-Prag, D., Wang, X. F., Nizol, L., Iannaccone, A., Musch, D. C., Bush, R. A., Salem, N., et al. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0353 · Cited by 61 · see citing works
Molecular ophthalmology: an update on animal models for retinal degenerations and dystrophies
Hafezi, F. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.8.922 · Cited by 61 · see citing works
Ross, R. J., Zhou, M., Shen, D., Fariss, R. N., Ding, X., Bojanowski, C. M., Tuo, J., & Chan, C.-C. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.01.014 · Cited by 60 · see citing works
Self-citationJoachim, S. C., Bruns, K., Lackner, K. J., Pfeiffer, N., & Grus, F. H. (2007) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-006-0429-9 · Cited by 60 · see citing works
Vasireddy, V., Vijayasarathy, C., Huang, J., Wang, X. F., Jablonski, M. M., Petty, H. R., Sieving, P. A., & Ayyagari, R. (2005) · PubMed · Cited by 60 · see citing works
Miceli, M. V., Newsome, D. A., Tate, D. J., & Sarphie, T. G. (2000) · Current Eye Research · doi:10.1076/0271-3683(200001)2011-hft008 · Cited by 59 · see citing works
Leys, A., Vanrenterghem, Y., Van Damme, B., Snyers, B., Pirson, Y., & Leys, M. (1991) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf00166300 · Cited by 57 · see citing works
Ambasudhan, R., Wang, X., Jablonski, M. M., Thompson, D. A., Lagali, P. S., WONG, P. W. K., Sieving, P. A., & Ayyagari, R. (2003) · Genomics · doi:10.1016/j.ygeno.2003.10.004 · Cited by 54 · see citing works
Lysosomal enzymes in ocular tissues and diseases
Hayasaka, S. (1983) · Survey of Ophthalmology · doi:10.1016/0039-6257(83)90125-x · Cited by 54 · see citing works
Won, J., Smith, R. S., Peachey, N. S., WU, J., Hicks, W. L., Naggert, J. Κ., & Nishina, P. M. (2008) · Visual Neuroscience · doi:10.1017/s0952523808080723 · Cited by 53 · see citing works
Majji, A. B., Cao, J. M., Chang, K. Y., Hayashi, A., Aggarwal, S., Grebe, R. R., & de Juan, E. (2000) · PubMed · Cited by 51 · see citing works
Modulated expression of secreted Frizzledrelated proteins in human retinal degeneration
Jones, S. E., Jomary, C., Grist, J., Stewart, H. J., & Neal, M. J. (2000) · Neuroreport · doi:10.1097/00001756-200012180-00012 · Cited by 51 · see citing works
Javitt, N. B., & Javitt, J. C. (2009) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32832af468 · Cited by 50 · see citing works
Angiogenesis inhibitors under study for the treatment of lung cancer
Shepherd, F. A., & Sridhar, S. S. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00144-2 · Cited by 50 · see citing works
Molecular Genetic Characterization of the Senescence-Accelerated Mouse (SAM) Strains
Kitado, H., Higuchi, K., & Takeda, T. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.6.b247 · Cited by 49 · see citing works
Cherepanoff, S., Mitchell, P., Wang, J. J., & Gillies, M. C. (2006) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2006.01281.x · Cited by 47 · see citing works
Flagged first, then by citations
Research works printed but not linked: 5
- Chang, 1998, A new mouse model of retinal dysplasia and degeneration (rd7), Invest. Ophthalmol. Vis. Sci., 39
- Collins, 1913, A pathological report upon a case of Doyne's choroiditis (‘honeycomb’ or ‘family choroidits’), Ophthalmoscope, 11, 537
- Hutchinson, 1875, Symmetrical central chorioretinal disease occurring in senile persons, R. London Ophthalmol. Hosp. Rep., 8, 231
- Rudolf, 2004, Accumulation of lipid particles in Bruch's membrane of LDL receptor knockout mice as a model of age-related macular degeneration, Ophthalmologe, 101, 715
- Sorsby, 1949, A fundus dystrophy with unusual features, Br. J. Ophthalmol., 33
Cited by
Sorted by citations
Animal models of age related macular degeneration
Pennesi, M. E., Neuringer, M., & Courtney, R. J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.06.003 · Cited by 391 · see citing works
Mechanisms of age‐related macular degeneration and therapeutic opportunities
van Lookeren Campagne, M., LeCouter, J., Yaspan, B. L., & Ye, W. (2014) · The Journal of Pathology · doi:10.1002/path.4266 · Cited by 382 · see citing works
Noncanonical autophagy promotes the visual cycle
Kim, J.-Y., Zhao, H., Martinez, J., Doggett, T. A., Kolesnikov, A. V., Tang, P. H., Ablonczy, Z., Chan, C.-C., Zhou, Z., Green, D. R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.012 · Cited by 347 · see citing works
Self-citationZhao, C., Yasumura, D., Li, X., Matthes, M., Lloyd, M., Nielsen, G., Ahern, K., Snyder, M., Bok, D., Dunaief, J. L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44303 · Cited by 303 · see citing works
Age related macular degeneration and drusen: Neuroinflammation in the retina
Buschini, E., Piras, A., Nuzzi, R., & Vercelli, A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.011 · Cited by 230 · see citing works
Yao, J., Jia, L., Khan, N., Lin, C., Mitter, S. K., Boulton, M. E., Dunaief, J. L., Klionsky, D. J., Guan, J.-L., Thompson, D. A., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1041699 · Cited by 130 · see citing works
Lyzogubov, V. V., Bora, P. S., Wu, X., Horn, L. E., de Roque, R., Rudolf, X. V., Atkinson, J. P., & Bora, N. S. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2016.03.021 · Cited by 45 · see citing works
TLR9 Ligand CpG-ODN Applied to the Injured Mouse Cornea Elicits Retinal Inflammation
Chinnery, H. R., McLenachan, S., Binz, N., Sun, Y., Forrester, J. V., Degli-Esposti, M. A., Pearlman, E., & McMenamin, P. G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.09.041 · Cited by 46 · see citing works
Hammadi, S., Tzoumas, N., Ferrara, M., Meschede, I. P., Lo, K., Harris, C., Lako, M., & Steel, D. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082870 · Cited by 44 · see citing works
- Authors
- Ramkumar, H. L., Zhang, J., & Chan, C.-C.
- Affiliations
- Northwestern University (US)
- National Institutes of Health (US)
- Corresponding author
- Chan, Chi-Chao
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 29
- Issue
- 3
- Pages
- 169-190
- ISSN
- 1350-9462 (ISSN-L)
- PMC
- PMC2854213
- OpenAlex
- W2058407555
- Semantic Scholar
- ab85119619942de2e81d9e4b6acd8715b28cbb30
- Cited by
- 163
- References
- 235
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 11 · 2023: 12 · 2022: 10 · 2021: 7 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 8 · 2016: 5 · 2015: 13 · 2014: 16 · 2013: 16 · 2012: 10
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Progress in Retinal and Eye Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Eye Institute (ZICEY000461, ZIAEY000222, ZIAEY000418)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- dry age-related macular degeneration, retinal ultrastructure, lipofuscin accumulation, A2E, drusen, photoreceptor atrophy, retinal pigment epithelium, Stargardt disease, Sorsby fundus dystrophy, oxidative stress
- MeSH terms
- Aging, Animals, Disease Models, Animal, Humans, Mice, Transgenic, Mutation, Retina, Mice, Geographic Atrophy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review